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ABSTRACT
The naturally occurring organic polycations, the polyamines spermidine, spermine and their
precursor putrescine, are essential for cellular proliferation and differentiation. Their intracellular
level is maintained by strictly regulated metabolic pathways. In order to investigate the functions
and metabolism of polyamines, several genetically manipulated rodent lines have been generated.
Activation of polyamine catabolism in transgenic rats overexpressing spermidine/spermine N1-
acetyltransferase (SSAT) under the control of heavy metal-inducible metallothionein I (MT)
promoter results in a rapid depletion of spermidine and spermine and leads to the development of
severe acute pancreatitis. Previous studies have shown that prophylactic administration of a stable
spermidine analog, a-methylspermidine (MeSpd), can prevent the development of zinc-induced
acute pancreatitis and restore the delayed liver regeneration after partial hepatectomy of MT-SSAT
transgenic rats.
In this work, the role of polyamines in other experimental models of pancreatitis, the pathogenesis
of polyamine depletion-induced pancreatitis and the therapeutic potential of methylpolyamines were
investigated. Activation of polyamine catabolism and depletion of higher polyamines were evident
in both cerulein and L-arginine experimental models of pancreatitis, and also in two human
pancreatic specimens obtained from patients with acute pancreatitis. Early pathogenesis in MT-
SSAT transgenic rats involved the activation of cathepsin B and trypsinogen, whereas prior
administration of MeSpd inhibited the activation of both proteases. Importantly, the therapeutic
administration of MeSpd or a,w-bismethylspermine (Me2Spm) could dramatically protect MT-
SSAT transgenic rats from pancreatitis-associated mortality.
The ability of stereoisomers of methylpolyamines to protect pancreatic integrity and support cellular
growth was also tested. Although only (S,S)-Me2Spm was metabolized to MeSpd, both (R,R)- and
(S,S)-enantiomers were equally effective in preventing the development of pancreatitis and
restoring liver regeneration in MT-SSAT transgenic rats. In vitro, all stereoisomers of both MeSpd
and Me2Spm effectively rescued cells from acute cytostasis caused by inhibition of polyamine
biosynthesis with a-difluoromethylornithine (DFMO). However, only (S)-MeSpd was able to
support growth after prolonged exposure to DFMO. 2D-immunoblot analysis of eukaryotic
translation initiation factor 5A (eIF5A) indicated that only (S)-MeSpd could serve as a precursor of
hypusine, a unique aminoacid derivative essential for the synthesis of functional eIF5A.
The physiological relevance of alternative splicing of SSAT pre-mRNA was also investigated. The
alternative splice variant was targeted to a protein synthesis-dependent degradation pathway known
as nonsense-mediated mRNA decay. Furthermore, the intracellular polyamine level regulated the
balance of the two splice variants: polyamine supplementation favored the generation of the
productive variant, subsequently resulting in decreased polyamine levels, whereas polyamine
depletion favored the production of the alternative, unproductive variant. Thus, polyamine-regulated
unproductive splicing and translation represents a novel posttranscriptional regulation mechanism of
SSAT.
In conclusion, these findings emphasize the importance of polyamine homeostasis for cellular
proliferation and for the integrity and normal function of the liver and the exocrine pancreas, and
open up possibilities for novel therapeutic approaches.
National Library of Medicine classification: QT 120, QU 61, QU 450, QY 58, WI 702, WI 805
Medical Subject Headings: Acetyltransferases; Animals, Genetically Modified; Disease Models, Animal;
Homeostasis; Liver/metabolism; Liver Regeneration; Pancreas/metabolism; Pancreatitis/therapy;
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1 INTRODUCTION
The initial discovery of polyamines (spermine) was made as early as 1678 by Antonie van
Leeuwenhoek (van Leeuwenhoek 1678); their chemical formula, however, was not elucidated until
1924 (Dudley et al., 1924). Since then, many functions of polyamines have been clarified, but there
are still open questions, especially related to the physiological roles of the individual polyamines.
Polyamines are basic, water-soluble, low-molecular weight aliphatic amines (Tabor and Tabor
1984). At physiological pH they exist as fully protonated polycations, and exert many of their
biological effects through undergoing ionic interactions with anionic cellular components such as
RNA, DNA and acidic phospholipids. They differ from metal cations in the way that the positive
charges are distributed along the conformationally flexible carbon chain, thus allowing a variety of
interactions and functions.
Polyamines are found in all living cell types, with the highest concentrations occurring in tissues
which have active protein synthesis and secretory functions such as pancreas, prostate and testis.
Most microorganisms contain only putrescine and spermidine but not spermine, while polyamines
with longer or branched chains are present in some species. Even though spermine does not seem to
be of vital importance for proliferation, in addition to being a reservoir of spermidine, it has several
important functions based on its structural feature as an organic tetravalent cation. The importance
of polyamines for cellular proliferation is supported by the findings that the intracellular polyamine
content as well as the activity of their biosynthetic enzymes increase rapidly when growth is
induced, whereas polyamine depletion leads to cessation of growth. Furthermore, enhanced
polyamine biosynthesis has been found in several types of tumor cells. Intracellular polyamine
levels are maintained by a complex interplay between biosynthesis from amino acid precursors,
uptake of polyamines originating from diet or intestinal microorganisms, interconversion, terminal
degradation and efflux. Each step is tightly regulated by several mechanisms in order to maintain
the delicate balance of polyamines since failure of these mechanisms can lead to cell death or
transformation.
Several genetically manipulated rodent lines have been generated to investigate the metabolism and
specific functions of the individual polyamines. These animals are deficient or overexpress the key
enzymes involved in polyamine metabolism (Jänne et al., 2004; Jänne et al., 2005). The first animal
model targeted the rate-controlling enzyme of polyamine biosynthesis, ornithine decarboxylase
(ODC, E.C. 4.1.1.17) (Halmekytö et al., 1991). Unexpectedly, despite the increased ODC activity
and accumulation of putrescine, these mice were able to maintain tissue levels of spermidine and
16
spermine. Activation of the polyamine interconversion pathway via overexpression of
spermidine/spermine N1-acetyltransferase (SSAT, E.C. 2.3.1.57) proved to be a far more effective
way to diminish cellular polyamine pools, leading to significant depletion of spermidine and
spermine and accumulation of putrescine and acetylated spermidine (Pietilä et al., 1997). These
mice displayed a striking phenotype characterized by early loss of hair and subcutaneous fat
deposits, wrinkling of the skin at old age, female infertility (Pietilä et al., 1997) and perturbations in
energy metabolism (Pirinen et al., 2007). Similar changes were also evident in another transgenic
mouse line overexpressing SSAT under the control of heavy metal-inducible mouse metallothionein
I (MT) promoter (Suppola et al., 1999). The MT promoter directs the expression of the transgene
mainly to the liver and pancreas, which are the organs mainly responsible for heavy metal removal.
In MT-SSAT transgenic rat line, administration of a nontoxic dose of zinc sulphate resulted in a
rapid depletion of the higher polyamines and the development of severe acute pancreatitis that
closely resembled the human disease (Alhonen et al., 2000). The importance of polyamines on the
integrity and normal function of pancreas is supported by the finding that prophylactic treatment
with a stable spermidine analog, a-methylspermidine (MeSpd), has been demonstrated to prevent
the development of zinc-induced acute pancreatitis (Räsänen et al., 2002). Likewise, MeSpd was
shown to support liver regeneration of partially hepatectomized MT-SSAT transgenic rats, which
normally exhibit delayed regeneration due to postoperative induction of the transgene and
subsequent polyamine depletion (Alhonen et al., 2002). This metabolically stable structural mimetic
of spermidine was able to replenish spermidine pool even under the conditions of intensively
activated polyamine catabolism, where the natural polyamines would be diminished by acetylation,
excretion or degradation.
This study aimed to expand our knowledge regarding the role of polyamines in regulation of SSAT,
cellular proliferation and development of acute pancreatitis. It was found that MeSpd therapy
dramatically reduced pancreatitis-associated mortality in MT-SSAT rats. We also obtained evidence
that activation of polyamine catabolism and depletion of higher polyamines is a general event in the
development of acute pancreatitis in other experimental models, and possibly also in human
pancreatitis. Similar molecular mechanisms appeared to be involved in the early pathogenesis of
polyamine depletion-induced pancreatitis as in other experimental models, and these changes could
be counteracted by prior administration of MeSpd.
As polyamines can be mutually interconverted, elucidating the physiological functions of each
individual polyamine is a challenging task. Inhibitors of key metabolic enzymes as well as synthetic
polyamine analogs have been developed as tools to address these questions. Using stereochemically
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pure isomers of MeSpd and Me2Spm, we observed that all stereoisomers of MeSpd and Me2Spm
were interchangeable in their abilities to rescue cells from polyamine depletion-induced acute
cytostasis evoked by difluoromethylornithine (DFMO), although only the (S,S)-isomer, but not the
(R,R)-isomer, of Me2Spm was converted to MeSpd. Likewise all the stereoisomers prevented the
development of zinc-induced pancreatitis and restored delayed liver regeneration in MT-SSAT
transgenic rats. However, only (S)-MeSpd could serve as a precursor of hypusine, a unique amino
acid adduct essential for the production of functional eukaryotic translation initiation factor 5A
(eIF5A), and thus support growth for a prolonged period. Furthermore, the results revealed the
dormant stereospecificity of spermine oxidase and deoxyhypusine synthase. Thus, the stereoisomers
of a-methylated polyamines were demonstrated to be excellent tools to study hypusine-dependent
and -independent effects of polyamines on cellular processes and to dissect the specific roles of each
individual polyamine.
In addition, a novel posttranscriptional regulation mechanism for SSAT was found. In the early
2000’s, several research groups reported the existence of a novel splice variant for SSAT mRNA.
Our results revealed that changes in the intracellular polyamine level could regulate the ratio of the
two splice variants. Increased polyamine levels shifted the balance towards productive variant,
whereas decreased polyamine levels favored the production of the alternative variant (SSAT-X),
which was rapidly targeted for protein synthesis-dependent degradation pathway known as
nonsense-mediated mRNA decay. This type of regulation is known as regulated unproductive
splicing and translation (RUST).
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2 REVIEW OF THE LITERATURE
2.1 POLYAMINE METABOLISM AND FUNCTION
2.1.1 Polyamine biosynthesis
In eukaryotic cells, the polyamines spermidine and spermine and their precursor diamine putrescine,
are synthesized de novo from two amino acids, L-arginine and L-methionine (Fig.1) (reviewed in
Tabor and Tabor 1984). L-Arginine is converted to L-ornithine, from which putrescine is produced
by a reaction catalysed by ODC, the rate-controlling enzyme in polyamine biosynthesis. The higher
polyamines, spermidine and spermine, are produced by sequential addition of aminopropyl groups
to putrescine by spermidine synthase (E.C. 2.5.1.16) and spermine synthase (E.C. 2.5.1.22),
respectively. The rate-controlling step in the formation of higher polyamines is the formation of the
aminopropyl donor, decarboxylated S-adenosylmethionine, by S-adenosylmethionine decarboxylase
(AdoMetDC, E.C. 4.1.1.50) (Pegg et al., 1998).
2.1.2 Polyamine interconversion and terminal degradation
Polyamines are catabolized by two different pathways: the interconversion and terminal degradation
pathways. The interconversion cycle is driven by cytosolic SSAT, which is induced by natural
polyamines and their structural analogs as well as a variety of other compounds and stress factors
(Table I) (Seiler 2004). N1-acetylspermine and N1-acetylspermidine formed by acetylation of
spermine and spermidine are subsequently cleaved by peroxisomal, flavin adenine dinucleotide-
dependent polyamine oxidase (PAO, E.C. 1.5.3.11) to yield spermidine and putrescine, respectively.
The enzyme catalysis produces also hydrogen peroxide and a reactive aldehyde, 3-
acetamidopropanal. While the SSAT/PAO system is responsible for converting spermidine and
spermine back to putrescine, the most recently discovered enzyme in the polyamine pathway,
spermine oxidase (SMO, EC 1.5.3.3), converts spermine directly to spermidine without the
acetylation step (Niiranen et al., 2002; Vujcic et al., 2002). Like PAO, SMO generates hydrogen
peroxide and reactive aldehyde (3-aminopropanal) as by-products. In most tissues, the PAO activity
is so high that the levels of N1-acetylated polyamines are undetectable and a transient rise can be
detected only in cancer cells (which have low PAO activity) or when SSAT is highly induced
(Casero and Pegg 1993). Thus SSAT, together with AdoMetDC, controls the flux through the
interconversion cycle. Acetylation also facilitates the excretion of polyamines. Additionally, by
reducing the charge, it may serve as a rapid way to decrease the potency of polyamine binding to
anionic intracellular sites (Seiler 1987). N1-acetylspermine can also be further acetylated to its
N1,N12-diacetyl derivative by cytosolic SSAT and subsequently converted to putrescine by PAO
(Vujcic et al., 2000).
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As an alternative to N1-acetylation, spermidine and putrescine can be N8-acetylated by nuclear, non-
inducible N8-acetyltransferase, which can also acetylate histones (Libby 1980). The majority of N8-
acetylspermidine is transported to cytosol where it is deacetylated back to spermidine by N8-
acetylspermidine deacetylase (EC 3.5.1.48), and there may serve as a reservoir for spermidine.
Additionally, its function may be to inactivate nuclear spermidine by converting it to a form which
can more easily cross the nuclear membrane (Desiderio et al., 1992; Libby 1978).
The terminal degradation pathway involves the oxidative deamination of polyamines at the primary
amino group by copper-dependent amine oxidases such as diamine oxidase (DAO, EC 1.4.3.6) or
serum amine oxidase (SAO) (Seiler 2004; Seiler and Heby 1988). SAO is present at very low levels
in human plasma, whereas high DAO activity is present in kidney, small intestine, placenta and
liver. Substrates for DAO include histamine, putrescine, spermidine, spermine, N1-
acetylspermidine, N1-acetylspermine and N8-acetylspermidine. Hydrogen peroxide and ammonia
are generated as by-products of DAO-catalyzed reactions. The spontaneous b-elimination of
acrolein from the DAO-generated aminoaldehydes may convert spermidine and spermine to
putrescine, which is, in theory, an alternative to acetylation-dependent polyamine degradation.
However, due to its very slow turnover rate and the efficacy of the other pathways in polyamine
homeostasis, the regulation of polyamine concentrations by DAO is considered unlikely.
2.1.3 Polyamine uptake and excretion
In addition to de novo synthesis, polyamines are taken up from extracellular sources, derived from
diet or microbes or from other cells that secrete polyamines (Seiler et al., 1996). The uptake occurs
via energy-requiring transport-mediated uptake system(s). The polyamine transporters have been
well documented in bacteria but despite years of research effort, the mammalian transporter gene(s)
have not yet been identified. In E. coli, three different transporters have been cloned and
characterized, and in yeast one gene has been identified so far (Igarashi and Kashiwagi 1999). Many
eukaryotic cells appear to have a single transporter for all three polyamines, with affinity increasing
as the positive charge increases (Seiler et al., 1996). On the other hand, in certain cell lines, separate
transporters for putrescine and spermidine have been identified. The transport system appears to be
relatively unspecific, since many polyamine analogs and compounds with a relatively poor
resemblance to natural polyamines, such as paraquat (N,N'-dimethyl-4,4'-bipyridylium), use the
same transporter(s). In general, polyamine uptake is regulated according to metabolic status of the
cell: negatively by the intracellular polyamine pool and positively by growth factors and oncogenes.
Induction of polyamine transport seems to require active RNA and protein synthesis. In addition to
inactivating ODC and blocking polyamine biosynthesis, antizyme (AZ), a small regulatory protein,
acts as a negative regulator of polyamine transport (Sakata et al., 2000; Suzuki et al., 1994).
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Polyamine export (efflux) is regulated by the growth status of the cell by inhibition in response to
growth stimuli and induction by growth retardation (Seiler et al., 1996). The exporter system(s) are
not well characterized. Efflux by diffusion is unlikely because of the hydrophilic nature of
polyamines, and the current opinion is that the export process is carrier-mediated (Mackarel and
Wallace 1994). It appears that uptake and excretion are mediated by different transporters, since
polyamine uptake-deficient mutant cells are still able to excrete polyamines to the medium
(Hyvönen et al., 1994). However, antizyme seems to regulate not only polyamine uptake but their
efflux as well (Sakata et al., 2000). In addition, putrescine, cadaverine and monoacetylspermine
efflux was shown to occur via a non-electrogenic antiporter, diamine exporter (Xie et al, 1997). The
main exported polyamines are acetylated polyamines and putrescine, while the intracellular
polyamine pool is mainly composed of spermidine and spermine (Seiler et al., 1996). It is believed
that spermine cannot be excreted itself but must be first acetylated or converted to spermidine.
Acetylated polyamines are very poor substrates for the polyamine uptake system, and therefore they
cannot be reaccumulated after passage through the cell membrane (Byers and Pegg 1989). They are
transported via blood to kidneys and excreted in urine. The products of terminal degradation are
also normal urinary excretory constituents (Seiler 2004).
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Figure 1. Overview of polyamine metabolism. Terminal degradation pathways are not shown.
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2.1.4 Properties and functions of polyamines
2.1.4.1 Interactions with polynucleotides
Polyamines possess a flexible molecular structure that allows interactions with various targets, and
thus they can influence numerous cellular processes. Since they are fully charged molecules at
physiological pH, these polycations exert many of their effects via electrostatic interactions with
anionic structures, such as DNA, RNA, anionic phospholipids and negatively charged protein
groups. While some of these interactions many be purely electrostatic and replaceable by inorganic
cations, other actions are known to be specific to the length of the aliphatic carbon chain.
One of the earliest discoveries made in polyamine research was that polyamines could stabilize
DNA (Tabor 1962), and that polyamine binding to DNA could induce chromosome condensation
(Hougaard et al., 1987). Spermidine-induced condensation occurs when there is one spermidine
molecule per eight nucleotides; at this concentration there is a complete neutralization of the
charges on the histones and chromatin phosphates (Fredericq et al., 1991). The structural change in
chromatin may be additionally modulated through histone acetylation, since polyamines affect
histone acetyltransferase activity (Dod et al., 1982). Micromolar concentrations of polyamines have
been shown to modulate the conformational transition of DNA by promoting its usual right-handed
B-conformation to the left-handed Z-form (Thomas and Messner 1986). The physiological
importance of Z-DNA is not well understood, but it has been implicated in gene regulation, DNA
processing, and genetic instability (Wang and Vasquez 2007). Polyamines have been recently
shown to exist in aggregates in the nucleus of replicating Caco-2 cells (D'Agostino et al., 2006).
These nuclear aggregates consist of ion-bonded polyamines and phosphate anions, and they carry a
net positive charge. The DNA-binding properties of the polyamines, especially spermine, may
account for their protective role in various processes, such as preventing endonuclease-mediated
DNA fragmentation (Brune et al., 1991), inhibiting lipid peroxidation (Hernandez et al., 2006) and
reducing the damage caused by singlet oxygen (Ha et al., 1998; Khan et al., 1992), alkylating agents
(Rajalakshmi et al., 1978) and radiation (Newton et al., 1996; Spotheim-Maurizot et al., 1995).
Compaction of DNA apparently reduces the accessibility of DNA to damaging agents. Since
polyamines are present in the millimolar range within cells, they are believed to play a significant
role in DNA stabilization in vivo. Thus, polyamines significantly contribute to the maintenance of
the structural integrity of DNA and the conformation of chromatin.
Polyamines are believed to be closely involved in the processes of protein synthesis. They are
known to stimulate translation in rabbit reticulocyte lysate (Ogasawara et al., 1989; Snyder and
Edwards 1991), bind tRNA (Peng et al., 1990) and stabilize ribosomes in vitro (Igarashi et al., 1982;
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Kakegawa et al., 1986). The subcellular distribution of polyamines has not been clearly elucidated
because the polyamines may become redistributed during cell homogenization and processing.
According to one estimate, most of the spermidine and spermine exist in a complex with RNA, at
least in rat liver and bovine lymphocytes (Watanabe et al., 1991). These results are supported by
immunoelectron microscopy studies in rats using spermine and spermidine-specific antibody,
highlighting their localization in free and attached ribosomes of the rough endoplasmic reticulum
(Fujiwara et al., 1998; Shin et al., 2006; Tanabe et al., 2004). In contrast, using subcellular
fractionation in non-aqueous media, Sarhan and Seiler claimed that polyamines exist mainly in the
nucleus (Sarhan and Seiler 1989).
2.1.4.2 Interactions with proteins and phospholipids
Polyamines can undergo electrostatic interactions with various acidic protein structures. These
interactions can affect protein conformations, and in this way they can influence enzyme activity,
the integrity of structural proteins, or their susceptibility to degradation. For example, polyamines
change the substrate preference of nuclear protein kinase NII by inducing a conformational change
(Hara and Endo 1982) and affect the structure and stability of estrogen-receptor complexes (Thomas
and Kiang 1987). In particular, spermine is known to modulate and block many types of ion
channels, such as strong inward rectifier K+ channels and some types of Ca2+-permeable AMPA (a-
amino-3-hydroxy-5-methyl-4-isoxazole propionic acid) and kainate receptors (Williams 1997).
Polyamines act as agonists at the NMDA (N-methyl-D-aspartate) subtype of the glutamate receptor,
involving two or more extracellular polyamine binding sites.
Polyamines can affect membrane stability by interacting with anionic phospholipids or negatively
charged residues of membrane proteins (Mager 1959; Schuber 1989; Tadolini and Varani 1986). In
addition to increasing membrane integrity, physiological concentrations of polyamines have been
shown to enhance phosphatidylinositol kinase activity on cellular membranes (Vogel and Hoppe
1986), probably by lowering the magnesium requirement of this enzyme (Smith and Snyderman
1988). This polyamine modulation may have important effects on downstream signaling targets of
polyphosphoinositides.
In addition to ionic interactions, polyamines can be covalently bound to proteins through the action
of calcium-dependent transglutaminases (E.C. 2.3.2.13.) (Greenberg et al., 1991; Williams-Ashman
and Canellakis 1980). Transglutaminases catalyze the posttranslational modification of proteins by
transamidation of distinct glutamine residues. The covalent cross-links are stable and thus result in
increased tissue stability. Several distinct transglutaminases have been characterized; these enzymes
undertake specific functions in important biological processes such as blood coagulation, apoptosis,
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epidermal differentiation and hair follicle formation. Another important and very specific role of
polyamines in posttranslational protein modification is the formation of hypusinated eIF5A (Park et
al., 1981).  Spermidine serves as the sole precursor of an unusual amino acid, hypusine {Ne-[4-
amino-2(R)-hydroxybutyl]lysine}. The hypusine residue is unique to eIF5A, in which it is formed
posttranslationally in a two-step process: first deoxyhypusine is produced by deoxyhypusine
synthase (EC 2.5.1.46) which transfers the 4-aminobutyl group of spermidine to lysine-50 in the
eIF5A precursor protein. Deoxyhypusine is then hydroxylated by deoxyhypusine hydroxylase (EC
1.14.99.29) (Cooper et al., 1984). Mature eIF5A has been shown to be absolutely required for
eukaryotic cell proliferation (Byers et al., 1992; Schnier et al., 1991). Originally it was thought that
eIF5A would function as a translation initiator, but it now seems that it has other functions.
Formation of functional eIF5A is inhibited not only by depletion of spermidine but also in the
presence of excess putrescine (Tome et al., 1997). The half-life of eIF5A is reported to be very long,
over a week in some cell lines (Bergeron et al., 1998; Nishimura et al., 2005; Torrelio et al., 1987).
2.1.4.3 Cell proliferation and transformation
Apart from spermidine serving as the precursor for hypusine synthesis, polyamines also
independently influence cell growth. In a similar manner to cyclins, polyamines are required for
active cell cycle progression. Induction of ODC and the subsequent rise in polyamine levels
promote cell cycling and stimulate proliferation, whereas ODC inhibition blocks the cell cycle
(Oredsson 2003). On the other hand, it has been known for a long time that overexpression of ODC
is associated with cell transformation (Auvinen et al., 1992; Auvinen et al., 1997; Hölttä et al.,
1993; Moshier et al., 1993; Russell and Snyder 1968). Since ODC overproducing cells have
typically high putrescine concentrations with only minor changes in spermidine and spermine pools,
it is possible that this elevation of the putrescine pool is responsible for the acquisition of the
malignant phenotype. This proposal is supported by findings that inactivation of ODC by DFMO
prevents transformation and even reverses the transformed phenotype, while polyamine
supplementation restores the transforming potential (Hölttä et al., 1993; Peralta Soler et al., 1998).
Surprisingly, life-long overexpression of human ODC does not predispose the transgenic mice to
enhanced tumorigenesis, although they have increased ODC activity and an expanded putrescine
pool (Alhonen et al., 1995). However, they are more susceptible to induced papilloma formation
(Halmekytö et al., 1992). Similarly, mice with skin-targeted ODC overexpression have increased
rate of spontaneous papilloma formation and as expected, are more susceptible to induced skin
carcinogenesis than nontransgenic mice (O'Brien et al., 1997). Moreover, overexpression of
antizyme in the skin delays the onset of tumor development and reduces the formation of induced
papillomas (Feith et al., 2001).
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Activation of polyamine catabolism in cells transfected with tetracycline-regulated SSAT leads to
lowering of spermidine and spermine pools, followed by inhibition of cell growth (Vujcic et al.,
2000). This growth inhibition cannot be reversed by exogenous polyamine supplementation, since
the intense activation of polyamine catabolism leads to a rapid excretion or degradation of the
natural polyamines. The high amount of putrescine, generated by compensatory induction of ODC,
further accelerates the polyamine cycle, with no net accumulation of spermidine and spermine.
Thus, rather than inducing ODC in order to produce putresine, a more feasible way to slow down
this cycle is to inhibit ODC with DFMO. The flux of the polyamine cycle can have marked effects
on the levels of many metabolites, causing centrally important substrates to become consumed or
toxic products to accumulate (Jänne et al., 2006). For example, each cycle consumes four ATP
equivalents (two ATP and two acetyl-coenzyme A molecules). The polyamine flux may explain the
controversial results obtained from different models of tumorigenesis. In the skin, targeted
overexpression of SSAT was found to increase the susceptibility to chemically induced
carcinogenesis (Coleman et al., 2002). In another tumor model, SSAT overexpressing mice crossed
with Apc(Min/+) mice (heterotzygous mutation in adematous polyposis coli gene) which are highly
susceptible to the development of spontaneous intestinal adenomas, suffered 3- and 6-fold more
adenomas than Apc(Min/+) mice in small intestine and colon, respectively (Tucker et al., 2005). The
hybrid mice exhibited a marked accumulation of putrescine and N1-acetylspermidine in their tissues,
and these increases were even more prominent in tumor tissues. Furthermore, Apc(Min/+) mice
crossed with mice with targeted disruption of the SSAT gene had 45 % reduced putrescine pool and
developed 75 % fewer adenomas than normal Apc(Min/+) mice. By contrast, transgenic
overexpression of SSAT in prostate cancer-predisposed TRAMP (transgenic adenocarcinoma of
mouse prostate) mice reduced prostatic tumor growth, despite the enlarged putrescine and N1-
acetylspermidine pools (Kee et al., 2004). It thus appears that modulation of tumorigenesis by SSAT
may be tissue-specific, depending on the metabolic environment.
2.1.4.4 Cell death
There are numerous, but controversial studies about the role of polyamines in cell death.
Paradoxically both anti- and proapoptotic properties have been reported. Some studies indicate that
polyamine depletion induces apoptosis which can be prevented by polyamine addition, while others
support the view that excessive polyamine level induces apoptosis, and that polyamine depletion by
DFMO can prevent or delay apoptosis induced by various factors such as serum starvation,
dexamethasone, g-rays or heat shock. The current opinion seems to be that both low and excessive
amounts of polyamines can trigger cell death, i.e. the polyamine pools have to be maintained in a
narrow range (see Seiler and Raul 2005 for review).
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Not only the polyamines themselves but also their metabolites can mediate cell death. Several
studies have demonstrated the link between the induction of polyamine catabolism and cytotoxicity.
Hydrogen peroxide produced by PAO, SMO and DAO is known to cause cell death, which can be
prevented by addition of catalase or PAO/SMO inhibitor N1,N4-bis(2,3-butadienyl)-1,4-
butanediamine (MDL72527) (Ha et al., 1997). Interestingly, Pledgie and colleagues reported that
SMO is the primary source of hydrogen peroxide generated in response to polyamine analog
induction (Pledgie et al., 2005); however, this might be dependent on cell line, because cancer cells
generally have higher SMO activity than normal cells. Another toxic by-product of polyamine
metabolism is 3-aminopropanal, formed for example by SMO-mediated spermine oxidation. 3-
Acetamidopropanal (generated by PAO) is believed to be less toxic, but it can form 3-
aminopropanal by spontaneous decomposition. Furthermore, acrolein, which can be formed from 3-
aminopropanal, is especially toxic (Houen et al., 1994). Therefore an alternative metabolic pathway
for 3-acetamidopropanal, catalysed by aldehyde dehydrogenase, may protect cells from acrolein
cytotoxicity (Averill-Bates et al., 1994). It should be noted that the extracellular formation of these
toxic compounds is more cytotoxic than their intracellular formation, because of the lack of
protective enzymes, extracellular catalase and aldehyde dehydrogenases. Therefore, in cell culture
supplemented with bovine serum or fetal bovine serum without amine oxidase inhibitor (such as
aminoguanidine), the natural polyamines are degraded into toxic metabolites, and the resulting cell
death is sometimes misinterpreted as "polyamine-mediated cytotoxicity" (Sharmin et al., 2001).
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2.2 REGULATION OF THE KEY ENZYMES IN POLYAMINE METABOLISM
2.2.1 ODC
ODC has extremely short half-life and is highly inducible enzyme regulated by several mechanisms.
The ODC gene is highly conserved among human, mouse and rat, both within the coding and
promoter regions. It is considered as an immediate early gene, and contains response elements for
several trans-acting factors, such as cAMP-response element, insulin response element and Sp1
binding sites. ODC gene also contains binding site for oncogenes such as c-Myc (Bello-Fernandez
et al., 1993). Mitotic stimuli induces transcription of ODC (Kahana and Nathans 1984; Katz and
Kahana 1987). In a similar manner to oncogenes and genes involved in proliferation, ODC encodes
a long 5'-untranslated region (5'UTR), which forms an extensive secondary structure (Manzella and
Blackshear 1990). This stem-loop structure represses the translation of ODC mRNA, and is
responsible for polyamine-mediated translational regulation where translation is enhanced at low
polyamine concentrations and inhibited at high concentrations (Ito et al., 1990).
The stability of ODC enzyme protein is mediated through its regulatory protein, antizyme. Increased
intracellular polyamine level triggers a +1 ribosomal frameshift on the decoding AZ mRNA, thus
allowing the functional AZ protein to be expressed. AZ binds to ODC and the resulting ODC-AZ
complex is subsequently degraded by the 26 S proteasome. This degradation does not involve
ubiquinylation, as is the case with a majority of proteins directed to 26 S proteasome. The ODC
protein contains two PEST (proline-glutamate-serine-threonine)-rich regions , which also contribute
to its rapid degradation (Ghoda et al., 1992; Rogers et al., 1986). In addition to controlling ODC
degradation, AZ also seems to inhibit polyamine uptake by a currently unknown mechanism
(Mitchell et al., 1994). Another regulatory protein, antizyme inhibitor (AZI), can liberate ODC from
ODC-AZ-complex in response to growth stimuli (Keren-Paz et al., 2007). AZI is an ODC-like
protein (with no enzymatic activity) to which AZ binds with higher affinity than to ODC. Currently,
four antizyme isoforms have been found, of which AZ-1 is most strongly associated with the
degradation of ODC (Mangold and Leberer 2005). ODC activity is dependent upon the availability
of pyridoxal phosphate as a cofactor, thiol-group-containing reducing agents and the formation of
its active site by dimerization (Poulin et al., 1992).
2.2.2 AdoMetDC
The activity of AdoMetDC, the second rate-controlling enzyme of polyamine biosynthesis, is
decreased by spermidine and spermine, and increased by putrescine. This induction is due to
changes both in transcription and translation (Pegg et al., 1988). The protein level of AdoMetDC, is
controlled by spermidine and spermine via a negative feedback mechanism at the level of
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translation initiation (Hanfrey et al., 2005). The AdoMetDC mRNA upstream open reading frame
(uORF) encodes a small peptide sequence, MAGDIS (methionine-alanine-glycine-aspartate-
isoleucine-serine), which controls ribosome access to the downstream reading frame. High
polyamine levels increase the stability of the ribosome pause at the uORF, and the stalled ribosomes
are unable to continue from the downstream cistron. At low polyamine levels the ribosome pauses,
but is then able to continue. AdoMetDC is synthesized as an inactive proenzyme, which is cleaved
autocatalytically into two unequal subunits. The active enzyme also contains covalently bound
pyruvate. Like ODC, also AdoMetDC harbors a PEST sequence, but it has not yet been established
whether it has an effect on the stability of the enzyme protein (Pegg et al., 1998).
2.2.3 PAO and SMO
The biochemical properties of purified polyamine oxidase were characterized by Hölttä (Hölttä
1977). The polyamine oxidases of both human (Vujcic et al., 2003) and murine (Wu et al., 2003)
origin were only very recently cloned. PAO is constitutively expressed in nearly all mammalian
tissues, generally has a high activity and a very slow turnover rate (Seiler et al., 1980). However,
recent studies have shown slight (~2-fold) inducibility by N-alkylated polyamine analogs (Vujcic et
al., 2003). PAO activity is especially high in liver and pancreas, and low in many types of tumors
compared to normal tissue (Seiler 1995). PAO gives rise to several splice variants, but their
abundance and significance is not known.
SMO is the most recently discovered enzyme in polyamine metabolism. Its expression is highly
induced by polyamine analogs mainly at the mRNA level, by increased transcription and mRNA
stabilization (Wang et al., 2001b; Wang et al., 2005a). SMO has at least nine splice variants, of
which two are known to possess catalytic activity (Cervelli et al., 2004). Both PAO and SMO are
inhibited by MDL72527, with an IC50 value of <0.1 mM (Wang et al., 2005b) and ~50 mM (Wang et
al., 2003), respectively. Although polyamine analogs such as DENSpm, DESpm and CHENSpm
(discussed later) induce the expression of both enzymes, they are substrates only for PAO (Vujcic et
al., 2003; Wang et al., 2003; Wang et al., 2005b).
2.2.4 SSAT
Like ODC and AdoMetDC, SSAT is a highly inducible, cytosolic enzyme with a very short half life
(<30 min) (Matsui and Pegg 1981). SSAT is induced by various antiproliferative and toxic agents
and physiological stress (Table I) (Casero et al., 2003; Ichimura et al., 1998). The expression of
SSAT is strictly regulated at each step from transcription to protein turnover. The SSAT gene
promoter has putative binding sites for a variety of transcription factors, such as peroxisome
proliferator-activated receptors (PPARs) (Babbar et al., 2003), GAGA factor, heat shock factor,
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AP1, AP2, E2F and harbors also multiple Alu-sequences which may also contribute to its
transcriptional regulation (Fogel-Petrovic et al., 1993a; Tomitori et al., 2002). Like many cell cycle-
related genes, SSAT is a TATA-less gene, the basal transcription of which is maintained by Sp1
factor binding to the GC-box located ~50 base pairs upstream from the transcription start site
(Tomitori et al., 2002). In contrast, the 9-bp consensus sequence 5'-TATGACTAA-3' known as
polyamine response element (PRE) accounts for polyamine-mediated transactivation (Wang et al.,
1998). It may also be responsible for stress-induced transactivation, as suggested by Tomitori
(2002) and others. PRE is associated with transcription factor Nrf-2 (nuclear factor E2-related factor
2), which is constitutively bound to PRE in polyamine analog-sensitive cell lines. In response to
polyamine or analog induction, another transcription factor, polyamine-modulated factor-1 (PMF-
1), binds to Nrf-2 through leucine zipper-coiled-coil interaction to modulate the transcription of
SSAT. Interestingly, PMF-1 exists in two isoforms produced by alternative splicing (Wang et al.,
1999; Wang et al., 2001a). Both of these variants possess a transactivation domain but the shorter
variant lacks an N-terminal coiled-coil domain required for the interaction with putative partners.
Predicted secondary structures of the isoforms are significantly different suggesting functionally
distinct roles, which currently remain to be elucidated. Experiments with protein synthesis inhibitors
such as cycloheximide have indicated that the transcription of SSAT is under the control of labile
repressor protein. The repressor protein was recently identified as inhibitor of kB (IkB), when
nuclear factor kB (NF-kB) was found to transactivate SSAT (Choi et al., 2006).
Polyamines and some of their analogs stabilize SSAT mRNA. SSAT mRNA has been found to exist
in at least two forms differing in their poly-A tail length, and this property might have some effect
on the half-life of the message (Fogel-Petrovic et al., 1993b). In addition, a novel splice variant of
SSAT, possibly coding for 71-amino acid C-terminal truncated protein, was initially found in
human cells infected with certain RNA viruses (Nikiforova et al., 2002). The variant was later
reported to be induced in response to UV-irradiation (Mita et al., 2004), hypoxia and iron
deficiency, and was suggested to possess antiapoptotic properties (Kim et al., 2005).
Based on studies with polyamine analogs, SSAT is also regulated by polyamines via enhancement
of translation (Butcher et al., 2007; Parry et al., 1995). According to recent evidence from Butcher
and colleagues, the translation of SSAT is repressed by an RNA binding protein, which is displaced
by polyamine analog. Like ODC, SSAT is degraded by the 26S proteasome, but is targeted by
ubiquitin instead of antizyme. SSAT does not have a PEST sequence, but related C-terminal
MATEE (methionine-alanine-threonine-glutamate-glutamate) motif responsible for its rapid
degradation (Coleman et al., 1995). The striking induction of SSAT in response to certain N-
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alkylated polyamine analog "superinductors" is mediated by the stabilization of the enzyme protein
(Coleman et al., 1995; Libby et al., 1989). Binding of an analog brings about a conformational
change which prevents the proteasomal degradation of the enzyme, and in this way prolongs the
enzyme half-life from less than 30 minutes up to several hours. The enzyme stabilization explains
why a thousand-fold induction of enzyme activity is often observed in response to synthetic
polyamine analogs, particularly in some cancer cell lines. It is, however, important to note that the
natural polyamines do not stabilize the enzyme protein as efficiently as some of their synthetic
mimetics, thus other regulation mechanisms may dominate.
A second SSAT-like enzyme was recently found (Chen et al., 2003). However, it was later shown
that although sharing 45 % identity and 61 % similarity with SSAT-1, the human SSAT-2 enzyme
does not acetylate polyamines, instead being involved in thialysine acetylation (Coleman et al.,
2004).
Table I. Factors that have been shown to induce SSAT (Casero and Pegg 1993).
Some SSAT-inducing factors
Natural polyamines
Spermidine, spermine
Synthetic polyamine analogs
Several N-alkylated, C-alkylated
Hormones and growth factors
Growth hormone, corticosteroids, estradiol, vitamin D derivatives, secretin, glucagon,
parathyroid hormone, corticotropin, catecholamines, serum growth factors, lectins, phorbol
esters
Toxic compounds
Carbon tetrachloride, folic acid, thioacetamide, ethanol, vanadate, selenite, arsenite,
lipopolysaccharides, free radical-generating agents, 2-deoxyglucose, dialkylnitrosamines,
monocrotaline
Drugs
Methylglyoxal bis(guanylhydrazone), adriamycin, 5-fluorouracil, methotrexate, ionophores,
carbamoyl choline, apomorphine, piribedil, 3-isobutylmethylxanthine, isoprenaline, lithium
salts, acetylsalicylic acid, sulindac
Other
Partial hepatectomy, heat shock, hypotonic shock, fasting, UV-radiation, g-radiation, virus
infection
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2.3 POLYAMINE ANALOGS
Polyamine analogs, which mimic the structure of natural polyamines, have been developed in an
attempt to elucidate the functions of polyamines in cellular metabolism, growth and differentiation
and to pinpoint the role of the individual polyamines. The fact that polyamines are an absolute
requirement for cell proliferation has meant that polyamine metabolism is an intensively studied
target for therapeutic intervention in many types of cancers. Cell growth is inhibited by depletion of
polyamines either by inhibition of their biosynthesis or by structural polyamine mimetics. The latter
technique is far more efficient, since it not only depletes cellular polyamines but also inhibits the
biosynthesis and uptake of the natural polyamines. Polyamine analogs and inhibitors of polyamine
biosynthesis have been tested as drug candidates either as monotherapy or in combination with
other antineoplastic agents. However, due to drug toxicity and the complex regulation of polyamine
homeostasis, no clinical applications for cancer treatment have emerged so far. In contrast,
polyamine depleting-strategies have been tested and shown to be effective in the treatment of
several parasitic diseases such as African sleeping sickness (trypanosomiasis) and malaria (Bacchi
and Yarlett 2002; Heby et al., 2007).
The first attempt to target polyamine biosynthesis was the inhibition of AdoMetDC with
methylglyoxal bis(guanylhydrazone) (MGBG) (Williams-Ashman and Schenone 1972). However, it
was not very specific and evoked mitochondrial toxicity. Since its development, a-
difluoromethylornithine (DFMO) (Metcalf et al., 1978), an irreversible inhibitor of ODC, has been
the most widely used compound to achieve polyamine depletion. Although it is relatively non-toxic,
it alone has failed as an anticancer agent because it depletes only putrescine and spermidine but not
spermine, and because its effects can easily be overcome by a number of compensatory
mechanisms. For example, rapidly growing tumor cells will induce polyamine uptake to maintain
the high polyamine levels needed for proliferation (Heston et al., 1984).However, promising results
have been recently obtained in the clinical trials of colon cancer chemoprevention with the
combination of DFMO and sulindac, a nonsteroidal anti-inflammatory drug (Gerner et al., 2007;
personal communication).
2.3.1 Unsaturated derivatives
By using synthetic unsaturated spermidine derivatives (Fig. 2.), Pegg and others showed that the cis
but not the trans isomer of the alkene analog of spermidine (N-(3-aminopropyl)-1,4-diamino-
cis/trans-but-2-ene) is a good substrate for spermine synthase (Pegg et al., 1991), thus providing the
first evidence for stereocontrol of spermine synthase. These compounds accumulate in cells to a
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much greater extent than spermidine, suggesting that although they use the polyamine transport
system, they do not downregulate the system as effectively as the natural polyamines. Both analogs,
and also non-metabolizable unsaturated spermine derivative, stimulate growth of spermidine-
depleted cells, although not as effectively as spermidine. In contrast to natural polyamines, the
unsaturated derivatives do not appear to be substrates for the interconversion pathway. Unsaturated
putrescine analog N,N'-bis(2,3-butadienyl)-1,4-butanediamine (MDL72527) (Fig. 2.) is a potent
inhibitor of both PAO and SMO (Bey et al., 1985; Bianchi et al., 2006).
Figure 2. Some unsaturated polyamine analogs at pH 7.4.
2.3.2 Aminooxy analogs
The aminooxy analogs were developed to investigate the importance of the charge distribution of
the polyamines on their physiological functions (Fig. 3.). Substitution of the terminal
aminomethylene group by aminooxy one gives rise to isosteric analogs and causes a decrease in the
pKa value of the primary amino group from ~10 to ~5.5. Aminooxypropylamine (APA), an analog
of putrescine, is a potent inhibitor of ODC, spermidine synthase, AdoMetDC and DAO (Khomutov
et al., 1985; Mett et al., 1993; Poulin et al., 1989). Due to their cytostatic properties, APA and its
derivatives have been used in designing potential anticancer drugs (Stanek et al., 1992) and also as
tools to study hypusinated eIF5A (Park et al., 1993). Aminooxy analogs of spermidine, N-
(aminoethyl)-1,4-diaminobutane (AOE-PU) and 1-aminooxy-3-N-(3-aminopropyl)-aminopropane
(AP-APA) are competitive inhibitors and poor substrates of spermine synthase. They also inhibit
ODC, inactivate AdoMetDC and moderately inhibit cell proliferation in a dose-dependent manner
(Eloranta et al., 1990; Hyvönen et al., 1995). Spermine analogs include 1-(aminooxy)-3,8-diaza-11-
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aminoundecane (AO-SPM) and 1,10-bis(aminooxy)-3,8-diazadecane (BAO-SPM) (Khomutov et
al., 1996; Simonian et al., 2006). AO-SPM is taken up in the cell via the polyamine transporter, but
it does not influence the activities of either ODC or AdoMetDC (Turchanowa et al., 2002).
Although it can protect DNA from oxidative damage in the same way as spermine, there are
controversial reports about its effect on proliferation. Initial evaluation of the compound showed
that it inhibits cell growth in rapidly proliferating cells, but has no effect on slowly growing cells
(Khomutov et al., 1996), while later studies with Caco-2 cells have shown some growth-restoring
properties after polyamine deprivation (Turchanowa et al., 2002).
The use of aminooxy analogs of putrescine and spermidine has been limited by their lability to
acetylation and oxime production with carbonyl group-bearing molecules (Hyvönen et al., 1992;
Keinänen et al., 1993), while AO-SPM is stable (Turchanowa et al., 2002). In order to develop more
stable isosteric and charge-deficient polyamine derivatives, several different oxa-spermidine and
oxa-spermine analogs have been synthesized (Fig. 3.). They show cytotoxicity towards several
cancer cell lines (Kuksa et al., 2000).
NH2 O NH3
+
NH2 O
N
H2
+
NH3
+
N
H2
+
NH3
+NH2 O
NH2 O
N
H2
+
N
H2
+ O
NH2
NH2 O
N
H2
+
N
H2
+
NH3
+
NH3
+
N
H O NH3
+
APA
AOE-PU
AP-APA
BAO-SPM
AO-SPM
5-oxaspermidine
Figure 3. Some aminooxy and oxa analogs of polyamines at pH 7.4.
2.3.3 N-alkylated analogs
Among the different types of synthetic polyamines with growth inhibitory properties, the terminally
alkylated polyamine analogs (Fig. 4.) have been the most extensively studied and some of them are
currently under investigation in clinical trials as anticancer agents. These compounds are actively
transported via the polyamine transporter into cells (Porter et al., 1985) where they replace natural
polyamines effectively by downregulating the synthesis, activating the interconversion and
inhibiting the uptake of the natural polyamines. Although closely resembling their natural
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counterparts in structure, the N-alkylated analogs are incapable of fulfilling their cellular functions
(Casero and Woster 2001). In addition, they seem to inhibit cell growth not only by means of
polyamine depletion but also via inhibition of mitochondrial protein synthesis and ATP depletion
(Snyder et al., 1994). The production of toxic metabolites via induction of the interconversion
pathway may also contribute to their growth inhibitory properties.
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Figure 4. Some N-alkylated spermine analogs at pH 7.4.
2.3.4 C-alkylated analogs
Non-metabolizable gem-dimethylspermidine and tetramethylated spermine analogs (Fig. 5.) were
synthesized in the late 80's (Nagarajan et al., 1988). In contrast to N-substituted analogs, they seem
to fulfill functions of the natural polyamines and support growth of polyamine-depleted cells at least
in the acute, hypusine-independent phase. They are not substrates for spermine synthase, indicating
that the enzyme is sensitive to steric hindrance. Other dimethylated analogs, 5,8-
dimethylspermidine and 5,8-dimethylspermine are non-metabolizable and can replace the natural
polyamines, but like N-alkylated analogs they exert antiproliferative effects on tumor cells (Holm et
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al., 1988). Both analogs inhibit ODC but only the spermine analog inhibits also AdoMetDC.
a-Methyl-substituted spermidine, MeSpd (Fig. 5.), was synthesized because it was thought to
prevent the undesired metabolism of S-adenosyl-1,12-diamino-3-thio-9-azadodecane
(AdoDATAD), a specific spermine synthase inhibitor (Lakanen et al., 1992). Since MeSpd proved
to be a poor substrate for spermine synthase, it was of no use as an AdoDATAD substitution.
However, as it was not acetylated by SSAT, the metabolically stable spermidine analog was
considered to represent a useful tool to study polyamine metabolism, after which MeSpm and
Me2Spm were synthesized. MeSpm, having an aminopropyl moiety, is not stable, while MeSpd is
slowly converted to MeSpm by the action of spermine synthase. Although Me2Spm is not a
substrate for SSAT/PAO, it is not entirely stable, as it is converted to MeSpd by SMO to some
extent both in vitro and in vivo (Järvinen et al., 2005). The methylpolyamines have very similar
physical properties, e.g. pKa values, as their natural counterparts and are equally effective in the B-
to Z-DNA transition (Varnado et al., 2000). In addition, they are able to restore acute cytostasis of
DFMO-treated cells, with MeSpd being the most potent (Lakanen et al., 1992). Since they are not
substrates for serum amine oxidase, they can be used without inhibitors such as aminoguanidine.
In contrast to the natural polyamines and gem-dimethylspermidines, a-methylpolyamines are chiral
molecules. At present, studies with a-methylpolyamines have been carried out so far with racemic
compounds. Recently stereochemically pure optical isomers of MeSpd, MeSpm and Me2Spm were
synthesized (Grigorenko et al., 2007) and their differential functions as natural polyamine
substituents are currently being tested in our laboratory.
Figure 5. Some C-alkylated polyamine analogs at pH 7.4.
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2.4 ACUTE PANCREATITIS
2.4.1 Experimental models
Acute pancreatitis is defined as an acute inflammatory disease of the exocrine pancreas
characterized by destruction and inflammation of the gland (Lankisch and Banks 1998). There are
two major etiologic factors, i.e. gallstone migration into the common bile duct and alcohol abuse;
these account for more than 80 % of all cases. Other rare causes are some drugs, lipid abnormalities
and hypercalcemia. The incidence of acute pancreatitis is increasing in western countries, especially
in USA and Finland (35-73/100 000) (Banks 2002). While patients with mild attacks usually
recover completely in a few weeks, about 10-20 % of patients develop severe disease with systemic
complications having a mortality rate of 15-20 %.
Because of the inaccessibility of human pancreas during the early phases of pancreatitis, most of our
knowledge about the pathophysiology of the disease is derived from experimental studies. Several
animal models for studying the pathogenesis and therapeutic intervention have been developed, with
variable severity and mortality rates. These models can be roughly divided into two categories
according to the severity of the disease: mild (edematous) and severe (necrotizing). The mild form
is characterized by interstitial edema with mild local inflammation and formation of ascites fluid,
whereas massive acinar cell necrosis, hemorrhage, inflammation and systemic complications occur
in severe disease. Interestingly, mild pancreatitis is associated with extensive apoptosis while severe
disease involves extensive necrosis but very little apoptosis, suggesting that apoptosis might in fact
be a favorable response (Kaiser et al., 1995). The most commonly used experimental model is the
administration of supramaximal doses of either a secretagogue, like cholecystokinin or its analog,
cerulein to rodents (Chan and Leung 2007; Lampel and Kern 1977). Cerulein produces mild
edematous pancreatitis in rats but severe disease in mice. Intraductal infusion of sodium
taurocholate represents a model of biliary pancreatitis and causes severe hemorrhagic disease with a
high mortality rate within hours of injection (Senninger 1992). Severe disease can be also induced
by administering large doses of L-arginine (Tani et al., 1990) or feeding young female mice with
cholin-deficient/ethionine-supplemented diet (Lombardi et al., 1975), although the relevance of
these models to human disease has been questioned. Common bile duct ligation (closed duodenal
loop) is another model mimicking gallstone-induced pancreatitis (Nevalainen and Seppä 1975).
There are not many good models for alcohol-induced pancreatitis, since it is difficult to induce
pancreatitis in rodents by feeding ethanol (Schneider et al., 2002). In order to induce pancreatitis,
combination with other drugs is commonly used. Werner and colleagues (2002) found that ethanol
infusion did induce a mild acute pancreatitis with changes closely resembling human alcoholic
pancreatitis.
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2.4.2 Early pathogenesis
Irrespective of the etiology, the pathogenesis of acute pancreatitis is believed to involve certain
common features. Three major stages of the disease can be described: after the initial acinar cell
damage, local inflammation of pancreas develops, followed by systemic inflammatory response
with distant organ dysfunction (Bhatia et al., 2005). Local pancreatic damage is thought to result
from premature, uncontrolled activation of the digestive enzymes and subsequent autodigestion of
the gland. Under physiological conditions, the digestive enzymes such as trypsinogen, proelastase,
chymotrypsinogen and procarboxypeptidase are synthesized in pancreatic acinar cells as inactive
zymogens to prevent their premature activation. They are stored in secretory granules from where
they are, upon stimulus, secreted to the apical pole of the acinar cell and activated by enterokinase
within the intestinal brush border. For further protection, several protease inhibitors limit zymogen
activation. Pancreatitis develops when these protective mechanisms fail and the zymogens become
activated in the pancreas, breaking down the tissue, thus causing edema, vascular damage,
hemorrhage and necrosis.
There is much debate about what is the ultimate triggering mechanism of the zymogen activation.
Some potential candidates are oxidative stress, disturbation of calcium signaling, impaired
pancreatic microcirculation, trypsinogen autoactivation, activation of trypsinogen by cathepsin B,
defective sorting of synthesized proteolytic enzymes and impairment of protease inhibitor function
(Chan and Leung 2007; Halangk and Lerch 2005). Premature activation of the digestive enzyme
cascade is believed to be orchestrated by trypsin, since it can promote its own activation as well as
activating the other enzymes. In human pancreas, three forms of trypsin are expressed: cationic,
anionic and mesotrypsinogen, of which the first is the most abundant. Trypsin is a highly active
enzyme that rapidly digests dietary proteins, activates other pancreatic enzymes and also regulates
pancreatic secretion through feedback system. Multiple lines of evidence demonstrate that
trypsinogen activation takes place in the early phase of the disease in several experimental models
of pancreatitis (Foitzik et al., 1994; Whitcomb 1999) as well as in human patients (Foitzik et al.,
1994). In fact, the amount of trypsinogen activation peptide, which is released during trypsinogen
activation, correlates with the disease severity and is considered as an early and sensitive clinical
marker of acute pancreatitis (Neoptolemos et al., 2000). There is also evidence showing that
mutations in the cationic trypsinogen gene (Whitcomb et al., 1996) or pancreatic secretory trypsin
inhibitor (Liddle 2004) can contribute to hereditary pancreatitis.
A lysosomal hydrolase, cysteine protease cathepsin B has been identified as a trypsinogen activator
(Berndt and Muller-Wieland 1970; Greenbaum et al., 1959; Saluja et al., 1997). Although most
37
lysosomal enzymes have an acidic pH optimum, cathepsin B seems to be functional over a wide pH
range and can cleave trypsinogen at neutral pH (Lerch et al., 1993). In recent years, lysosomes have
been recognized as alternative cell death mediators (Terman et al., 2006). Permeabilization of the
lysosomal membrane and subsequent enzyme leakage to cytosol in response to various cell death
stimuli can trigger either apoptosis or necrosis. Cathepsin B has been shown to directly activate
inflammatory caspases such as caspase-1 and caspase-11 in vitro (Vancompernolle et al., 1998).
According to the so-called ‘co-localization hypothesis’, the co-localization of digestive enzymes
and lysosomal hydrolases within the same intracellular compartment occurs, leading to zymogen
activation (Saluja et al., 1987; Watanabe et al., 1984). Studies with immunofluorescence and
subcellular fractionation have revealed that prior to acinar cell injury, the normal segregation of
digestive enzyme zymogens from lysosomal hydrolases is disrupted and cathepsin B and
trypsinogen become co-localized. This phenomenon seems to occur in all experimental models of
pancreatitis, although the mechanism of action appears to be different (Van Acker et al., 2002;
Yamaguchi et al., 1989; van Acker et al., 2006). In the secretagogue-induced model, the digestive
enzyme secretion is blocked, resulting in defective sorting of secretory granules and endocytic
vesicles, whereas the diet-induced model involves fusion of mature lysosomes and zymogen
granules. When vesicle trafficking is blocked by the phosphatidylinositide 3-kinase (PI3K)
inhibitor, wortmannin, fusion of the zymogen and lysosomal markers as well as activation of
trypsinogen are prevented (Singh et al., 2001). However, recent evidence indicates that although
cathepsin B initiates zymogen activation, inhibition of cathepsin B does not reduce the production
of proinflammatory cytokines and chemokines, or prevent F-actin redistribution, suggesting that
also other mechanisms are involved in the pathogenesis of pancreatitis (Van Acker et al., 2007).
Calcium is an important second messenger, promoting exocytosis of zymogen granules under
physiological conditions, and its free intracellular concentration is tightly regulated. In the early
phase of acute pancreatitis, these regulation mechanisms are overwhelmed leading to a sustained
elevation in the cytosolic Ca2+ concentration and disruption of calcium signaling (Kruger et al.,
2000; Niederau et al., 1999; Parekh 2000; Sutton et al., 2003). This event has been detected in many
experimental models of pancreatitis, induced by cerulein, bile salts, ethanol, fatty acid ethyl esters
or oxidative stress. Furthermore, the activation of trypsinogen (Saluja et al., 1999) and NF-kB (Han
and Logsdon 2000) require increased intracellular calcium. In the absence of calcium, trypsin is
inactivated by undergoing autolysis, whereas in the presence of calcium, trypsin remains active.
Another consequence of an elevated intracellular calcium level is the activation of cytosolic
calcium-dependent cysteine proteases, calpains, which have been shown to be involved in
pancreatic autodigestion (Virlos et al., 2004; Weber et al., 2004). According to ‘calpain-cathepsin’
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hypothesis, calpains cause lysosomal rupture and release of cathepsins leading to cell death
(Yamashima 2004).
Oxidative stress resulting from generation of free radicals and reactive oxygen species can induce
cell death, and it seems to be associated with the development of acute pancreatitis (Schulz et al.,
1999). Release of reactive oxygen species is detected very early, followed by lipid peroxidation and
depletion of cellular antioxidants such as reduced glutathione. Importantly, oxidative stress leads to
disturbance of intracellular calcium homeostasis, thereby evoking a cascade of events leading to the
development of pancreatitis (Klonowski-Stumpe et al., 1997).
There are numerous other mediators that have been shown to be involved in the development of
acute pancreatitis. Upregulation of the local renin-angiotensin system has been shown to contribute
to microcirculatory failure and oxidative stress (Leung 2007). Furthermore, the disturbance to the
pancreatic microcirculation seems to enhance the transition from edema to necrosis. In acute
pancreatitis, cell death occurs by both apoptosis and necrosis, and recent studies have noted that the
type of cell death may actually be an important determinant of the severity of the disease (Bhatia
2004; Bhatia et al., 1998). Proteins with protective functions in pancreatitis have also been
identified. Heat shock proteins (Hsp) are highly conserved cytoprotective molecules that act by
maintaining structural and metabolical integrity of various proteins. In tumor cells, Hsp70 has been
shown to translocate to lysosomal membranes and stabilize them (Gyrd-Hansen et al., 2004). Hsp70
induction confers protection against pancreatitis in experimental models (Bhagat et al., 2000;
Tashiro et al., 2002; Weber et al., 2000). An elegant study demonstrated that prior hyperthermia
induced the expression of Hsp70 and protected rats from pancreatitis while in vivo administration of
Hsp70-antisense oligonucleotides abolished this protective effect (Bhagat et al., 2002). It is also
noteworthy that Hsp70-deficient mice display spontaneous activation of trypsinogen (Hwang et al.,
2005) while its overexpression in the pancreas ameliorates acute pancreatitis (Bhagat et al., 2003).
2.4.3 Local and systemic inflammation
After the initial damage, acinar cells synthesize and release inflammatory mediators that recruit
inflammatory cells, which amplify the inflammatory reaction. The transcription factor NF-kB is
activated early in the course of pancreatitis and it is believed to be the major mediator in
proinflammatory cytokine and chemokine production. The local inflammatory response is
characterized by the production of proinflammatory cytokines such as interleukins IL-1, IL-6, IL-8,
tumor necrosis factor a (TNF-a), platelet-activating factor (PAF), and chemokines. Also
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antiinflammatory mediators such as IL-10, IL-2 and protease-activated receptor-2 are produced after
an initial burst of proinflammatory factors. The amplification of an uncontrolled inflammatory
cascade is thought to be responsible for the systemic dispersion of the inflammation. This involves
the production of vasoactive substances, inflammatory mediators, adhesion molecules and
chemokines, like bradykinin, prostaglandins, endothelin-1 and nitric oxide. The systemic
inflammatory response syndrome (SIRS) leads to multiorgan dysfunction, disorders of coagulation,
circulatory collapse, shock and ultimately to death. It is noteworthy that the mortality in acute
pancreatitis is related to the extent of SIRS rather than to the pancreatic damage itself. The most
common first sign of multiorgan dysfunction in humans is impaired lung function known as acute
respiratory distress syndrome (ARDS), but other organs such as liver and kidney may also be
affected. Early deaths are primarily caused by multiorgan dysfunction, but patients surviving
beyond the first attack can develop later complications such as fat necrosis, pseudocyst formation,
pancreatic abscess, infection of pancreatic necrosis and sepsis. Severe acute pancreatitis frequently
involves some disorders of hemostasis, which, in addition to sepsis, can trigger disseminated
intravascular coagulation (DIC). DIC is a complex thrombohemorrhagic complication with a high
mortality rate and its management is difficult even in the intensive care unit.
2.4.4 Experimental therapeutic approaches
Currently, there is no specific treatment for acute pancreatitis. The treatment is based on the
management of the disease by providing supportive care and preventing complications (reviewed in
Besselink et al., 2007). Intravenous fluid resuscitation is routinely used for compensating
hypovolemia, and analgesics are given to relieve pain. There is still much controversy over the
prophylactic use of antibiotics, surgery and the type of nutrition for severe acute pancreatitis. Recent
studies have indicated that early enteral feeding is superior to parenteral feeding. Antibiotics seem
to be beneficial only in patients with infected pancreatitis whereas the use of probiotics has revealed
promising results in reducing infectious complications. Surgical intervention, used for removing the
infected, necrotic, parts of the pancreas, is now being postponed to a later phase of the disease, and
non-invasive strategies are being increasingly used.
There has been much work done in attempt to develop a specific therapy for acute pancreatitis and
especially its severe forms (Table II). The vast majority of these studies have been carried out in
animals and only a few have been tested in the clinic, with mainly disappointing results.
Antisecretory drugs such as somatostatin and its analog octreotide were among the first “specific”
drugs to be tested. Although exhibiting a dramatic reduction in the mortality rate in rats (Greenberg
et al., 1999), there are no consistent results of any beneficial effect in humans. According to some
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analyses, it has shown a slight beneficial effect in human severe pancreatitis (Andriulli et al., 1998),
while according to others it is ineffective (Greenberg et al., 2000; McKay et al., 1997). Another
therapeutic strategy aims at compensating for the imbalance between proteases and antiproteases,
but once again, conflicting results have been published. Whereas some reports found no efficacy
(Schmid et al., 1996), a recent meta-analysis indicated that protease inhibitors, such as gabexate
mesilate, nafamostat mesilate or aprotinin can actually decrease the mortality rate in severe
pancreatitis in human patients (Seta et al., 2004). Recently, inhibition of cathepsin B either
chemically (Van Acker et al., 2002) or by genetic deletion of cathepsin B gene (Halangk et al.,
2000) has been shown to significantly reduce trypsinogen activation and prevent pancreatic damage
in animal model. However, cathepsin B-deficient mice exhibited no differences in serum IL-6 level
or pancreatic and lung myeloperoxidase activity, supporting the view that trypsin activity affects the
extent of local pancreatic damage but not its systemic manifestations.
Other methods, such as chelation of intracellular calcium by 1,2-bis(2-aminophenoxy)ethane-
N,N,N?,N?-tetraacetic acid tetrakis(acetoxymethyl ester) (BAPTA-AM) (Mooren et al., 2003),
stabilization of cytosolic pH with weak base chloroquine (Seyama et al., 2003) and inhibition of
PI3K activation by wortmannin (Singh et al., 2001) have all shown some efficacy in experimental
models. However, many of these therapies are still far from being tested in the clinic, and although
they do seem to be beneficial in animal models, they may not show any efficacy in humans. Several
pathways may have to be modulated at the same time by using drug combinations. Approaches
targeted at the very early phase are problematic, because all these events take place within a very
short period of time, thus offering a short therapeutic window during which it is theoretically
possible to modulate the severity of human pancreatitis. These novel treatment approaches might
still be utilized as prophylactics in patients with high risk of pancreatitis or to prevent post-ERCP
pancreatitis.
Another attractive and widely studied therapeutic approach is to reduce inflammation by cytokine
antagonists or antioxidants. These methods target either local or systemic inflammation or both. The
benefit of antioxidants is controversial. At present, it seems that antioxidants, such as resveratrol, N-
acetylcysteine, ascorbic acid and selenium may have some efficacy in preventing pancreatitis in
high-risk patients and in chronic disease (Schulz et al., 1999). Inhibition of NF-kB, the "master
regulator" of inflammatory molecules, by various drugs has resulted in an attenuation of the disease.
For example, curcumin, a non-toxic phytoagent, inhibited NF-kB and ameliorated both alcoholic
and non-alcoholic experimental pancreatitis (Gukovsky et al., 2003). Likewise blockade of NF-kB
target TNF-a either with polyclonal antibody (Hughes et al., 1996) or with soluble receptors
(Norman et al., 1996) decreased mortality and severity of the disease. Inhibition of prostaglandin
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synthesis by specific cyclooxygenase-2 inhibitors reduced systemic inflammation in animals
(Foitzik et al., 2003); however, they are unlikely to be tested in humans since these drugs have
serious thromboembolic adverse effects.
Receptor blockers of endothelin-1, intracellular adhesion molecule-1 (ICAM-1) or PAF have been
effective in alleviating the microcirculatory disorders in severe experimental pancreatitis (Eibl et al.,
2002; Foitzik et al., 1999). Although successful in animals, treatment with the PAF antibody,
lexipafant did not prevent organ failure in human pancreatitis (Johnson et al., 2001). However,
promising results have been obtained from immunomodulation with IL-10. A reduction of
pancreatic lesions and systemic inflammation as well as a reduction in the mortality rate was
reported in various experimental models using either recombinant IL-10 (Rongione et al., 1997) or
IL-10 agonist (Osman et al., 1998), whereas IL-10 antibodies (Van Laethem et al., 1998) or genetic
deletion of IL-10 gene (Gloor et al., 1998) worsened the disease. Importantly, prophylactic injection
of recombinant human IL-10 was shown to protect from post-ERCP pancreatitis in humans (Deviere
et al., 2001).
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Table II. Some examples of experimental treatment approaches for acute pancreatitis.
Target Treatment References
Proteases
Protease activation Antiproteases
(protease inhibitors) (Schmid et al., 1996; Seta et al., 2004)
Cathepsin B Cathepsin B inhibitors (Saluja et al., 1997; Van Acker et al., 2002)
Inflammatory response
NF-kB NF-kB inhibitors (Gukovsky et al., 2003)
TNF-a TNF-a antibody (Hughes et al., 1996)
TNF-a soluble receptor (Norman et al., 1996)
IL-10 Recombinant IL-10 (Rongione et al., 1997; Deviere et al., 2001)
IL-10 agonist (Osman et al., 1998)
IL-1 IL-1 receptor antagonist (Norman et al., 1995)
PAF PAF antibody (Eibl et al., 2002; Foitzik et al., 1999;
  Johnson et al., 2001)
ICAM-1 ICAM-1 antibody (Eibl et al., 2002; Foitzik et al., 1999)
Inflammation IFN-g (Hayashi et al., 2007)
Prostaglandins Cyclooxygenase-2 inhibitors (Foitzik et al., 2003; Song et al., 2002)
Other mediators
Exocrine secretion Antisecretory drugs
(Andriulli et al., 1998; Greenberg et al.,
1999)
Protease-activated receptor-2-
activating peptide
(Sharma et al., 2005)
pH reduction pH stabilization (Seyama et al., 2003)
Calcium Calcium chelators (Mooren et al., 2003)
PI3K signaling PI3K inhibitor (Singh et al., 2001)
Oxidative stress Antioxidants (Schulz et al., 1999)
Renin-angiotensin
system
Angiotensin II receptor
blockers
(Tsang et al., 2003; Tsang et al., 2004)
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3 AIMS OF THE STUDY
Polyamines play a pivotal role in cellular proliferation and tissue integrity. This work aimed to
investigate the regulation of SSAT and to further study the consequences of activated polyamine
catabolism in vivo and in vitro.
The specific aims were to
§ investigate the role of polyamine catabolism in different experimental models of
acute pancreatitis (I)
§ examine the therapeutic effect of a-methylated polyamine analogs on the outcome of acute
pancreatitis in MT-SSAT transgenic rats with activated polyamine catabolism (I)
§ study the pathogenesis of acute pancreatitis in MT-SSAT transgenic rats (I, III)
§ investigate the function of alternative splice variant of SSAT and its regulation by
polyamines and their analogs (II)
§ characterize the effects of optical isomers of a-methylated polyamine analogs on
proliferation and polyamine homeostasis in vitro and in vivo (IV)
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4 MATERIALS AND METHODS
4.1 CHEMICALS AND ANTIBODIES
MeSpd and Me2Spm were synthesized essentially as described earlier (Grigorenko et al., 2005).
Synthesis of their pure stereoisomers was recently published (Grigorenko et al., 2007). Diethylated
analogs were synthesized essentially as in (Rehse et al., 1990). DFMO was obtained from ILEX
Oncology, Inc. [Methyl-3H]-thymidine (specific radioactivity 71.2 Ci/mmol) was purchased from
Perkin Elmer. Fluorometric cathepsin B activity kit was from BioVision. Anti-Upf1 antibody was
purchased from Bethyl Laboratories, anti-cyclophilin and anti-cathepsin B from Upstate, and anti-
eIF5A from BD Biosciences. Anti-SSAT antibodies against recombinant full-length SSAT (1-171)
and recombinant SSAT-X (1-71), or against synthetic peptides ([N-terminal mixture of 1-25 and 26-
71]; [C-terminal four overlapping 20-amioacid-containing peptides from exon 6]) were generated in
rabbits at the National Laboratory Animal Center, University of Kuopio.
4.2 ANIMAL EXPERIMENTS
All animals were housed in a 12-h-light/dark-cycle facility with free access to food and water. The
Institutional Animal Care and Use Committee of the University of Kuopio and the Provincial
Government approved the animal experiments.
4.2.1 Induction of pancreatitis in MT-SSAT rats (I, III, IV)
Transgenic Wistar rats harboring mouse metallothionein I-promoter-driven SSAT gene construct
were used (Alhonen et al., 2000). Acute pancreatitis was induced by activating the transgene
expression via MT promoter by administration of a non-toxic dose of zinc sulphate (10 mgZn/kg i.p.
in distilled water) in a volume of 0.2 ml/kg body weight. The therapeutic effects of MeSpd (50
mg/kg i.p. in saline) and Me2Spm (25 mg/kg i.p. in saline) were studied by injecting the analogs 4
and 8 hours after induction of pancreatitis and the prophylactic effect by injections 20 and 4 hours
before the induction.
4.2.2 L-arginine and cerulein models (I)
To induce severe necrotizing pancreatitis, L-arginine was administered to nontransgenic Wistar rats
as a single dose 2.5 g/kg i.p. and the animals were sacrificed after 24h. To induce mild edematous
pancreatitis, cerulein was given to nontransgenic Wistar rats as seven hourly i.p. injections of 50
mg/kg and the animals were sacrificed 1 h after the last injection. The prophylactic effect of MeSpd
was studied by injecting the analog 20 and 4 hours before the induction of pancreatitis.
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4.2.3 Partial hepatectomy (IV)
Partial hepatectomy of MT-SSAT transgenic and their nontransgenic littermates were performed as
described in (Higgins and Anderson 1931), by removing two-thirds of the liver. MeSpd was injected
20 and 4 hours before the operation. [3H-Methyl]thymidine (10 mCi) was administered
intraperitoneally 30 min before sacrificing the animals by decapitation (24 h after hepatectomy).
4.2.4 In vivo studies of alternative splicing of SSAT (II)
MT-SSAT transgenic mice (Suppola et al., 1999) and their nontransgenic littermates received one
injection of DENSpm (125 mg/kg i.p. in saline). The mice were sacrificed 24 h after injection.
4.3 PATIENTS (I)
Human pancreatic samples were obtained from Tampere University Hospital from patients
undergoing pancreaticoduodenal resection or necrosectomy for acute necrotizing pancreatitis. The
samples were frozen in liquid nitrogen and stored at -70 °C before assays.
4.4 SUBCELLULAR FRACTIONATION
After the rats were sacrificed, pancreas was quickly removed, and trimmed from fat in ice-cold
buffer containing 250 mM sucrose, 10 mM MOPS and Complete EDTA-free protease inhibitor
tablet (Roche), pH 7.4. A portion of the pancreas was homogenised in 10 x vol of the same buffer
with Teflon homogenizer. The homogenate was centrifuged at 1000 x g for 5 min at +4 °C to pellet
nuclei and unbroken cells. The resulting "postnuclear supernatant" was subsequently centrifuged at
13 000 x g for 30 min at +4 °C and the obtained supernatant was designated as "cytoplasmic
fraction". After sonication for 3 min at +4 °C, protein content was measured from both fractions
using BioRad Coomassie Brilliant Blue.
4.5 CLONING OF SSAT AND SSAT-X CDNAS (II)
The SSAT and SSAT-X cDNAs containing exons 1–6 and 1–6 including X, respectively, were
amplified from the pool of first strand cDNA. The resultant PCR products were gel-purified,
digested with SalI and NotI and cloned into the vector CMV/myc/cyto (Invitrogen) cut with the
same enzymes. The structures of all constructed plasmids were confirmed by automated sequencing.
Plasmid DNAs were prepared using QIAFilter Maxi kit (Qiagen) following the manufacturer's
protocol.
4.6 RT-PCR AND QUANTITATIVE RT-PCR (II)
Total RNA was extracted with TRIzol Reagent (Invitrogen) and treated with Dnase I (Dna-free,
Ambion) according to the manufacturer's instructions. Cytoplasmic RNA was purified with RNeasy
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as described by the manufacturer (Qiagen). One microgram of Dnase-treated RNA was used for
first-strand cDNA synthesis using oligo-dT primers and AMV reverse transcriptase (Promega) in a
total volume of 25 ?l. A 2-?l aliquot of the first-strand cDNA was used for PCR in a mixture
containing 2.5 ?l 10× buffer with MgCl2, 0.5 ?l dNTP mix (10 mM each), 25 pmol forward and
reverse primers, and 1 U DyNAzyme DNA polymerase (Finnzymes) in a total volume of 25 ?l.
PCR products were isolated from 2 % agarose gel and purified with QIAEX II according to the
manufacturer's instructions (Qiagen) and sequenced using Thermo Sequenase CY5 Dye Terminator
Kit and A.L.F.express DNA Sequencer (Amersham Biosciences).
Quantitative RT-PCR was performed using 6 ng (RNA equivalents) of cDNA as template, and gene
specific Assay-by-Design (AbD) probe and primer sets and TaqMan Universal PCR Master Mix
with or without AmpErase UNG from Applied Biosystems in TaqMan 7700 (Applied Bio-systems).
The total amount of SSAT mRNA was quantified using an AbD targeted to the junction of exons 4
and 5. The amount of the intronless, exon X-containing SSAT mRNA was quantified using an AbD
targeted to the junction of exons 3 and X. Plasmids containing SSAT and SSAT-X were mixed 1:1
and the resulting mixture was serially diluted to produce standard curves. Data for SSAT-X mRNA
were normalized to total SSAT mRNA and presented as relative to the means of untreated groups,
unless otherwise indicated. The total SSAT mRNA was chosen for normalization, because it shows
the balance between SSAT-X and SSAT mRNA. 18S rRNA was used as the control in experiments
where SSAT-X and SSAT mRNA amount was shown separately.
4.7 HUMAN RECOMBINANT SMO KINETICS IN VITRO
Human recombinant SMO was prepared as described earlier (Järvinen et al., 2005) except omitting
the affinity purification step with polyamine conjugated Sepharose. The kinetic studies were carried
out twice with triplicates at five different (5 to 100 mM) substrate concentrations in 100 mM
glycine-NaOH at pH 9.5 containing 5 mM dithiotreitol. Enzyme stock solution was diluted with 50
mM sodium phosphate buffer (pH 8.0) containing 0.1 % Triton-X-100 prior to kinetic studies to
yield 0.1 to 4.0 mg/10 ml of SMO for each reaction mixture. Reactions were carried out and
analyzed as described in (IV).
4.8 CELL CULTURE EXPERIMENTS
4.8.1 Pancreatic acinar cells (I)
Dispersed acini (intact secretory units of 20 to 50 acinar cells) were freshly prepared from the
pancreas of male syngenic and transgenic rats by collagenase (Serva) digestion. Acinar biovolume
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was determined by a CASY system (Schärfe) and adjusted to a concentration of 2 mm3/ml. Acini
were cultured as described (Kruger et al., 2000). Effect of Zn2+ on intracellular trypsinogen
activation: freshly prepared acini were incubated for 2 hours by addition of ZnSO4 to the culture
medium at different concentrations. Effect of Me2Spm on zinc-induced trypsinogen activation:
syngenic and transgenic rats were treated by Me2Spm (25 mg/kg i.p.) as two doses 24 and 4 hours
before sacrifice. Me2Spm (1 mM) was added to all buffers used in acinar cell isolation and
incubation in vitro. In parallel to all in vitro experiments, separate aliquots of acini were incubated
without ZnSO4 but stimulated with the cholecystokinin analog cerulein (10 nM, 60 minutes). Under
these conditions, intracellular trypsinogen activation reached a maximum.
Intracellular trypsinogen activation. Acini were washed, resuspended in fresh medium (without
zinc or cerulein), transferred to 96-well microtiter plates, and the cell-permeable and trypsin-
specific substrate (CBZ-Ile-Pro-Arg)-2-rhodamine-110 (Molecular Probes) was added (10 ?M).
Intracellular released fluorochrome rhodamine-110 was quantified by cytofluorometry continuously
for 60 minutes (excitation 485 nm, emission 530 nm). Zinc-induced trypsinogen activation was
calculated as a percentage of the maximum activatable trypsinogen detected by the corresponding
cerulein experiments.
4.8.2 Prostate cancer cell lines (IV)
Human prostate carcinoma cell lines DU145 and LNCaP were obtained from American Type
Culture Collection. The cells were cultured in DMEM supplemented with 10 % fetal bovine serum
and 50 mg/ml gentamycin and grown at +37 °C, 10% CO2. To determine the ability of the
stereoisomers of MeSpd and Me2Spm to reverse DFMO-induced cytostasis, the cells were plated
(1x106 cells/10 cm plate) and incubated overnight, after which the medium was replaced with fresh
medium containing DFMO (5 mM) and a polyamine analog (100 mM). The cells were then
harvested by trypsinization, electronically counted and passaged (2x106 cells/10 cm plate) every
three days until day 12. The content of DFMO and analogs was maintained with each passage.
4.8.3 Other cell lines (II)
Primary fetal fibroblasts from MT-SSAT transgenic mice or their syngenic littermates (d16) were
isolated as described in (Alhonen et al., 1998). The cells were cultured in DMEM supplemented
with 10% fetal bovine serum and 50 mg/ml gentamycin and grown at +37 °C, 5 % CO2. The cells
were treated with protein synthesis inhibitors cycloheximide (10 ?g/ml or 50 ng/ml) or puromycin
(100 ?g/ml or 200 ng/ml) with or without 10 ?M DENSpm. For half-life measurements, the cells
were incubated up to 8 h with the transcription inhibitor, actinomycin D (5 ?g/ml). Small interfering
RNAs targeted to mouse Upf1 or negative control were chemically synthesized at Ambion. Fetal
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fibroblasts were electroporated using ECM 830 (BTX) in electroporation buffer (Ambion)
according to the manufacturer's instructions, plated on 6-well plates (225,000 cells/well), and
harvested after 72 h. DENSpm (10 ?M) was added 24 h after electroporation. After treatments, cells
were harvested by trypsinization and counted using a Coulter model ZM electronic cell counter
(Coulter Electronics). Mouse embryonic stem cells with targeted disruption of spermine synthase
gene were generated and cultured as in (Korhonen et al., 2001).
4.8.4 Viral studies (II)
HEK293 cells for viral studies (II) were obtained from American Type Culture Collection. For viral
transductions 4 × 106 cells were plated onto 100-mm plates 24 h prior to transduction. The
adenoviral vector Ad5 CMV contains no transgene under CMV promoter. Ad5 CMV was
propagated in HEK293 cells and purified with double CsCl gradients using standard methods and
titrated for the amount of viral particles with a spectrophotometer. Functional titer (PFU, 1.35 ×
1010) was determined with a plaque assay with an overnight infection in HEK293 cells. An
attenuated strain of Semliki Forest virus SFV A7 (74) was produced and titrated in BHK cells as
previously described (Tuittila et al., 2000) Prior to viral transductions, medium was removed from
the plates and viruses were applied onto the plates in appropriate medium containing 10% FCS for
SFV and 2% FCS for Ad5 CMV. All transductions were carried out with multiplicity of infection 1.
4.9 ANALYTICAL METHODS
SSAT and ODC activities were assayed according to (Bernacki et al., 1992). Polyamines and their
acetylated derivatives were determined by HPLC (Hyvönen et al., 1992). Ethylated analogs were
measured as in (Kabra et al., 1986). Plasma amylase activity and ALAT were determined using the
Microlab 200 analyzing system (Merck). Hematocrit values were measured with Ames microspin
centrifuge (Bayer Diagnostic) from blood samples obtained from femoral vein. Cathepsin B activity
was measured at room temperature using a commercial fluorometric kit (BioVision). Trypsin
activity was measured at room temperature from pancreatic homogenates with synthetic substrate Z-
Gly-Pro-Arg-p-nitroanilide (280 mM, Sigma) in a buffer containing 100 mM Tris-HCl pH 8.0, 0.1
mg/ml bovine serum albumin and 1 mM CaCl2. To measure non-specific background activity,
samples were incubated with 0.25 mg/ml soybean trypsin inhibitor (Sigma) before measurement.
Change in absorbance was monitored for 5 minutes at 15 s intervals using standard 96-well plate
reader set to 405 nm. Standard curves were obtained from serial dilutions from bovine pancreas
trypsin (Sigma) dissolved in 1 mM HCl.
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4.9.1 Northern blotting (II)
Total RNA (15 mg) were electrophoresed in 1.2 % agarose gel under denaturing conditions,
transferred to positively charged nylon membrane (Roche), and hybridized to digoxigenin-labeled
(Roche) single-stranded whole-length SSAT (exons 1–6) or exon X-specific cDNA probe and
detected by chemiluminescence.
4.9.2 Western blotting (II, III)
Cells (II) were lysed for 20 min on ice in a buffer containing 25 mM Tris (pH 7.4), 0.1 mM EDTA,
0.1% Triton-X-100, 1 mM dithiotreitol, and 1× Complete EDTA-Free protease inhibitor (Roche).
After centrifugation (15 min at 10 000 x g, +4°C) the supernatant was retained. Western blot was
performed with standard protocols and anti-SSAT and anti-Upf1 antibodies. Cyclophilin was used
as loading control. Pancreases (III) were homogenized with a Teflon homogenizer in a 3 x vol
buffer containing 25 mM Tris (pH 7.4), 0.1 mM EDTA and 1 mM dithiotreitol. The amount of
cathepsin B was determined from pancreatic homogenates (30 mg of total protein) by
immunoblotting with a polyclonal goat anti-rat cathepsin B antibody (1,5-2,0 mg/ml).
4.9.3 2D-PAGE (IV)
Different isoforms of eIF5A were determined by 2-dimensional gel electrophoresis followed by
immunoblotting as previously described (Taylor et al., 2007). The gels were blotted onto an
Immobilon FL membrane (Millipore). The membranes were scanned with a Typhoon Variable
Mode Imager (GE Healthcare).
4.9.4 Histological analyses (I, III, IV)
Formalin-fixed tissue specimens were embedded in paraffin, cut into 5-?m-thick slices and stained
with hematoxylin and eosin. The sections were scored according to (Niederau et al., 1986).  For
necrosis and vacuolization, the scores refer to an approximate percentage of cells involved.
Definitions for histological evaluation in study (I) in terms of necrosis and/or vacuolization are
normal (0 to 5% of necrosis), mild (5 to 30% of necrosis), moderate (30 to 50% of necrosis), and
severe (>50% of necrosis). Immunohistochemical analysis of proliferating cell nuclear antigen
(PCNA) (IV) was carried out as described earlier (Alhonen et al., 2002).
4.9.5 Transmission electron microscopy (III)
Pancreatic tissue specimens were prefixed overnight in 2.5 % glutaraldehyde in 0.1M cacodylate
buffer, washed in buffer followed by 2-hour postfixation in 1 % osmium tetroxide. Samples were
washed again, dehydrated in a graded series of ethanol and propylene oxide, and embedded in LX-
112. Ultrathin sections were cut from each block with an ultramicrotome.
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4.9.6 Statistical analyses
One-way analysis of variance with Dunnett´s or Bonferroni´s post-hoc tests was used for multiple
comparisons with the aid of a software package, GraphPad Prism (GraphPad Software). The same
software package was used for the analyses of enzyme kinetic data using Michaelis-Menten
equation with nonlinear fitting (IV). Survival data (I) were analyzed using Fisher's exact test and the
Kaplan-Meier method with log-rank test.
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5 RESULTS
5.1 POLYAMINES IN ACUTE PANCREATITIS (I, III)
5.1.1 Activation of polyamine catabolism is a general phenomenon in acute
pancreatitis (I)
The involvement of activated polyamine catabolism in nontransgenic experimental models of
pancreatitis and the possible protective role of a-methylated polyamine analogs were examined in
two different models. Activation of polyamine catabolism was observed both in L-arginine- (severe)
and cerulein-induced (mild) pancreatitis in nontransgenic rats, as evident by increased SSAT
activity, decreased spermidine and spermine pools and accumulation of putrescine in the pancreas.
Prophylactic MeSpd administration alleviated pancreatitis in the L-arginine but not in the cerulein
model, as measured by plasma a-amylase activity and histological scoring of pancreas. However,
there was no detectable MeSpd accumulation in the pancreases of cerulein-treated animals, unlike in
animals treated with L-arginine. A small number of pancreatic specimens from human patients were
also analysed for polyamine levels. In both patients with acute pancreatitis, spermidine and
spermine levels were decreased down to 2 and 24 % of normal levels, respectively.
5.1.2 a-Methylated polyamine analogs rescue MT-SSAT rats from acute pancreatitis-
associated mortality (I)
Administration of zinc sulphate (10 mgZn/kg i.p.) to MT-SSAT transgenic rats led to the
development of necrotizing severe pancreatitis within 24 h, the first signs being evident already
within 2 h. Given therapeutically, MeSpd and Me2Spm dramatically reduced pancreatitis-associated
mortality in MT-SSAT transgenic rats. Without any intervention, the mortality rate was 100 %
within 3 days, whereas injection of MeSpd or Me2Spm (50 or 25 mg/kg i.p., respectively) 4 and 8
hours after the zinc reduced the mortality rate to 20 % and 0 %, respectively (p < 0.001). Both
ALAT and hematocrit values were elevated at 24 h in zinc-treated rats but significantly reduced
with Me2Spm treatment. Analog treatment also protected animals from the later mortality (2 weeks
follow-up).
5.1.3 a-Methylated polyamine analogs prevent premature trypsinogen activation (I, III)
In order to gain insight into the early pathogenesis of zinc-induced pancreatitis, pancreatic acinar
cells were isolated from MT-SSAT rats for in vitro studies (I). Zinc sulphate concentration-
dependently increased cerulein-induced trypsinogen activation in transgenic acinar cells. Only a
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minor increase was seen in acinar cells from syngenic rats. Pretreatment of transgenic rats with
Me2Spm (20 and 4 hours) before acinar cell isolation prevented trypsinogen activation.
Activation of trypsinogen and cathepsin B was also studied in vivo (III). The first signs of
developing pancreatitis such as edema and intraperitoneal accumulation of ascitic fluid were seen
already at 2 h after zinc administration to MT-SSAT transgenic rats. Spermidine pool fell by 80 %
in 4 h, and by 90 % (maximum) in 8 h. Pancreatic cathepsin B protein amount and enzymatic
activity were elevated already 2 hours after the induction of pancreatitis. Trypsin activity was
increased 4 hours after the induction. Pretreatment of the rats with Me2Spm reduced the induction of
both enzymes. Transmission electron microscopy of pancreatic samples revealed disorganization of
endoplasmic reticulum, mitochondrial swelling and appearance of partially degranulated zymogen
granules, condensing vacuoles and large autophagosomes.
Pancreatic cytoplasmic fractions were prepared by subcellular fractionation from fresh tissue.
Increased amounts of both a-amylase (Fig. 6.) and cathepsin B (Fig. 7.) were found in the
cytoplasmic fraction early after the induction of pancreatitis. Pretreatment with MeSpd partially
prevented the translocation of amylase (Fig. 6.) and cathepsin B (Fig. 7.).
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Figure 6. Amylase activity (% of total activity) present in pancreatic cytoplasmic fractions of MT-
SSAT transgenic rats 1h and 3h after the induction of transgene with zinc. MeSpd was given as two
injections, 20 and 4 hours before the induction of pancreatitis. Results are means ± SD, n=4.
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Figure 7. The amount of cathepsin B in pancreatic cytoplasmic fractions of MT-SSAT transgenic
rats 4h after the induction of transgene with zinc. MeSpd was given as two injections, 20 and 4
hours before the induction of pancreatitis. The Western blots show both single-chain and double-
chain forms of the mature, active protein. Each lane represents an individual sample. The
experiment was repeated with similar results.
5.2 POLYAMINE-REGULATED UNPRODUCTIVE SPLICING AND TRANSLATION OF SSAT (II)
5.2.1 Alternative splicing of SSAT is regulated by intracellular polyamine pools
SSAT pre-mRNA gives rise to two messages, SSAT-coding and extra exon-containing message.
The effect of polyamine pool manipulation on alternative splicing of SSAT was first studied with
RT-PCR or quantitative RT-PCR. Addition of the natural polyamines (Spd, Spm; with 1 mM
aminoguanidine) or polyamine analogs such as MeSpd, Me2Spm or DENSpm to cells derived from
syngenic or MT-SSAT transgenic mouse fetuses, resulted in increased SSAT mRNA and decreased
SSAT-X mRNA levels. Similar changes in splicing of SSAT were seen in MT-SSAT transgenic
mouse liver 24 h after one intraperitoneal injection of DENSpm. In contrast, using DFMO or
MG132 to decrease the intracellular polyamine levels decreased the SSAT level and increased the
SSAT-X level. Since both treatments depleted polyamines but had opposite effects on SSAT
activity (DFMO decreased, MG132 increased SSAT activity), the polyamine level, and not the
SSAT protein itself, seemed to be the mediator of alternative splicing. DFMO and DENSpm
modulated splicing of SSAT both in normal and spermine-deficient embryonic stem cells, indicating
that either spermine or spermidine can elicit this function.
5.2.2 SSAT-X is a target for nonsense-mediated mRNA decay
Since exon X in SSAT mRNA, located between exons III and IV (of seven exons total), harbors
three in-frame stop codons, it potentially codes for C-terminal truncated 71-amino acid protein.
However, we did not detect the presence of this protein in any experimental conditions. In contrast,
after transfection of cells with cDNA coding for truncated protein with only exons I, II, III and X,
we detected this 71-amino acid protein by using metabolic labeling and immunoprecipitation with
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SSAT antibody. Based on the location of these stop codons, SSAT-X represents a potential target
for mRNA surveillance pathway known as nonsense-mediated mRNA decay (NMD). To verify this
hypothesis, we used two protein synthesis inhibitors, cycloheximide and puromycin, and siRNA-
mediated silencing of Upf1, an essential factor for NMD, to block NMD. All these approaches
resulted in accumulation of SSAT-X. We also found that SSAT-X was induced in HEK293 cells
infected with Semliki Forest virus (SFV) or transduced with adenovirus. SFV infection also induced
NMD-targeted splice variants of another gene, ABCC4 (multidrug resistance-associated protein 4).
To verify that polyamines modulated alternative splicing and not NMD, NMD was first blocked
with cycloheximide and DENSpm was added one hour later. After 7 hours, SSAT-X accumulation
in the presence of CHX was markedly reduced by DENSpm, pointing to a role in splicing. The
currenly known steps involved in SSAT regulation by polyamines and their analogs are summarized
in figure 8.
5.2.3 Effect of polyamine levels on alternative splicing of other gene products
Next we investigated whether polyamines affected on alternative splicing of other gene products
than SSAT. Manipulation of intracellular polyamine levels by DENSpm, Me2Spm, MG132 and
DFMO resulted in changes in the splicing pattern of several other genes, but most of the changes
were only marginal. The most prominent changes that correlated with polyamine levels were seen in
the splicing of cdc2-like kinase 1 (Clk1).
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Figure 8. Regulation of SSAT expression by polyamines and their analogs. Inhibition or stimulation
by polyamines and their analogs is indicated by (-) or (+).
5.3 ROLE OF POLYAMINES IN CELLULAR PROLIFERATION (IV)
5.3.1 Stereospecificity of spermine oxidase
Stereoisomers of Me2Spm were tested as substrates for human recombinant SMO. In vitro, SMO
strongly preferred the (S,S)-isomer of Me2Spm as a substrate, the efficiency of enzyme catalysis
(kcat/Km) being ~480-fold higher than for the (R,R)-isomer. In cultured DU145 and LNCaP cells, the
(S,S)-isomer was degraded to (S)-MeSpd, but no conversion of (R,R)-Me2Spm to (R)-MeSpd was
detectable.
5.3.2 Optical isomers of a-methylated polyamine analogs support cell proliferation
Polyamine depletion-induced cytostasis occurs in two, independent phases: an acute phase and a
later, hypusinated eIF5A depletion-induced phase. First the ability of stereoisomers of
methylpolyamines to support short term growth was tested in vitro and in vivo. All stereoisomers of
56
both MeSpd and Me2Spm effectively replaced natural polyamines, and were able to support the
growth of DFMO-treated DU145 or LNCaP prostate carcinoma cells for up to 6 days.
After partial hepatectomy of MT-SSAT transgenic rats, the initiation of liver regeneration is delayed
due to the postoperative induction of the transgene and subsequent polyamine depletion. This
proliferative blockade can, however, be overcome by a prior administration of either racemic
MeSpd or Me2Spm (Alhonen et al., 2002). Here, stereoisomers of methylpolyamines were given as
two intraperitoneal injections 20 and 4 hours before hepatectomy. Regeneration was assessed at 24h
postoperatively by measuring the rate of DNA synthesis (thymidine incorporation) and the number
of proliferating cells (PCNA labeling index). Only (S,S)-Me2Spm was converted to MeSpd in vivo.
Both (R,R)- and (S,S)-isomers of Me2Spm were equally effective as racemic MeSpd in reversing
the early proliferative block, irrespective of whether or not they were converted to MeSpd.
Similarly, these two isomers protected MT-SSAT transgenic rats from zinc-induced pancreatitis, as
assessed by the histological scoring (not shown) and plasma a-amylase activity.
Next, the ability of the stereoisomers of MeSpd and Me2Spm to support growth for a prolonged
DFMO exposure was tested. Surprisingly, only (S)-MeSpd was able to support growth of cultured
DU145-cells for over one week. According to 2D-immunoblotting of eIF5A, only (S)-MeSpd
produced functional hypusinated eIF5A, indicating that only it served as a substrate for
deoxyhypusine synthase.
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6 DISCUSSION
The activation of polyamine catabolism via the induction of SSAT has major consequences. As
shown in this present and our previous work, the induction of SSAT leads to cytostasis of cultured
cells, delays the initiation of rat liver regeneration after partial hepatectomy, and induces acute
pancreatitis. These changes are attributable to polyamine depletion, and can be prevented by stable
a-methylated polyamine analogs. Thus the regulation of polyamine metabolic enzymes plays a
pivotal role in many important cellular functions.
Many mediators play a role in the development of acute pancreatitis. Our previous and present (I)
results indicate that activation of polyamine catabolism is a general phenomenon in the pathogenesis
of pancreatitis. In addition to the situation in MT-SSAT transgenic rats, mice carrying the same
transgene, and mice with tetracycline-inducible SSAT develop pancreatitis when the transgene
expression is induced (Herzig et al., 2005). The causal relationship between polyamine depletion
and acute pancreatitis is also supported by other models of pancreatitis. For example, administration
of gossypol, a male antifertility agent derived from cottonseed, results in a striking activation of
polyamine catabolism in MT-SSAT transgenic rats and leads to the development of acute
pancreatitis (Räsänen et al., 2003). After administration of gossypol, a moderate activation of
polyamine catabolism and signs of mild pancreatitis are also seen in syngenic animals, but severe
pancreatitis develops only in transgenic rats where the higher polyamine pool is markedly depleted.
Activation of polyamine catabolism followed by spermidine depletion was also observed in L-
arginine and cerulein-induced experimental models of acute pancreatitis (I). Although the number
of human pancreatic specimens was small, the finding that polyamines were depleted in both
patients eith acute pancreatitis, supports our view that polyamine depletion is a general event in
acute pancreatitis. The fact that signs of pancreatitis were alleviated by MeSpd only in the SSAT
transgenic and L-arginine-induced models, but not in the cerulein-induced model, is explained by
the lack of MeSpd accumulation in the pancreases of cerulein-treated rats. The finding that MeSpd
reduced necrosis in necrotic models of pancreatitis (SSAT transgenic and L-arginine models)
suggests that polyamine depletion might be associated with the development of necrosis.
Intrapancreatic activation of trypsinogen is one of the earliest events in the pathogenesis of acute
pancreatitis. Our results (I, III) with MT-SSAT transgenic rats and pancreatic acinar cells isolated
from these animals reveal that an activation of cathepsin B and trypsinogen takes place early in
zinc-induced pancreatitis. Moreover, pretreatment of the rats with Me2Spm blocks cathepsin B and
trypsinogen activation, indicating that polyamine depletion occurs upstream of trypsinogen
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activation. Interestingly, basal trypsinogen activation (without zinc) in response to cerulein was over
2-fold higher in isolated acinar cells from transgenic rats than in cells obtained from syngenic rats
(I). This may result from the basally reduced spermidine/spermine pool in transgenic acinar cells,
further supporting the view that a sufficient pool of higher polyamines is needed for maintaining
pancreatic integrity. Indeed, the pancreas is the richest source of spermidine in mammals and has
also the highest molar ratio of spermidine to spermine (Rosenthal and Tabor 1956). This high
content of spermidine may be related to the ongoing active protein synthesis or to its secretory
function, since also the prostate has a high spermidine concentration. On the other hand, DFMO
seems to retard pancreatic growth (Morisset and Grondin 1987) but does not appear to interfere with
exocrine secretion (Haarstad et al., 1989). One prerequisite for trypsinogen activation by the
lysosomal hydrolase, cathepsin B, is that these two enzymes, which are normally located in different
cellular compartments, colocalize. This might take place via perturbed segregation of digestive
enzymes and lysosomal hydrolases, fusion of lysosomes with zymogen granules, or leakage of
lysosomal and zymogen granular contents into the cytoplasm. Polyamines are known to preserve the
integrity of cellular membranes (Powell and Reidenberg 1984; Schuber 1989, and references
therein), apparently through electrostatic interactions with acidic phospholipids or membrane
proteins (Mager 1959). In secreting cells such as exocrine pancreas, polyamines have been shown to
localize to secretory granules (Hougaard and Larsson 1986; Larsson et al., 1982). However, to date,
the polyamine content of isolated zymogen granule or lysosomal membranes has not been reported,
possibly due to redistribution of polyamines during subcellular fractionation. One may speculate
that the rapid detachment of polyamines from their binding sites leads to destabilization of
subcellular organelle membranes causing the release and premature activation of digestive
zymogens. This hypothesis is supported by our results from the subcellular fractionation, where the
cathepsin B and amylase contents became increased in the cytoplasmic fraction soon after the
induction of pancreatitis, concurrently with polyamine depletion, and these events were attenuated
by prior MeSpd administration (Fig. 6. & 7). Supporting evidence is provided by transmission
electron microscopy (III), which shows partially degranulated zymogen granules, indicating
leakage of granular contents. Similar morphological changes were observed in ethanol-induced
pancreatitis in rats (Werner et al., 2002). In that study, nonoxidative rather than oxidative
metabolites of ethanol caused the development of mild pancreatitis, and these metabolites (fatty acid
ethyl esters) are known to increase the fragility of pancreatic lysosomes (Haber et al., 1993) and
zymogen granules (Haber et al., 1994). It is also possible that polyamines can protect tissues by
directly interacting with and inhibiting some proteases, as reported in (Leviant et al., 1979).
Oxidative stress has been thought to contribute to the development of acute pancreatitis and even
suggested to be the ultimate triggering mechanism of the disease. Since the activation of SSAT
59
leads to the production of hydrogen peroxide and reactive aldehydes via PAO, one may speculate
that oxidative stress is the triggering mechanism of the disease in SSAT transgenic rat model.
However, the involvement of oxidative stress does not seem to make any major contribution to the
development of acute pancreatitis in these animals, as supported by the following findings. In MT-
SSAT rats, the combination of low-dose zinc with PAO/SMO inhibitor MDL72527 resulted in an
even worse outcome than with zinc alone (Alhonen et al., 2000). Similarly, DENSpm, a polyamine
analogue which induces SSAT, alone did not cause inflammation but the combination with
MDL72527 resulted in acute pancreatitis. A poorer outcome was also seen with the combination of
gossypol and MDL72527 in both syngenic and MT-SSAT transgenic rats (Räsänen et al., 2003). To
further verify the causal relationship between polyamine depletion and development of acute
pancreatitis, methylated polyamine analogs were used. Administration of MeSpd or Me2Spm could
prevent the onset of the disease, although their use apparently led to even more enhanced polyamine
catabolism with increased generation of hydrogen peroxide and reactive aldehydes by PAO
(Räsänen et al., 2002). All these findings emphasize that sufficient amounts of polyamines are
needed to preserve pancreatic integrity and function.
The specific target(s) of polyamine analogs or the cause of death in MT-SSAT transgenic rat
pancreatitis model is not exactly known. In general, the main cause of death during early
pancreatitis is shock or multi-organ failure. However, there were no overt macroscopical or
microscopical changes in the examined tissues, except in the liver, where some changes (such as
congestion) were seen. These changes were possibly related to the hepatic induction of SSAT and
were not secondary to pancreatitis, since methallothionein is also expressed in the liver. The
significantly increased hematocrit values in rats with pancreatitis indicate that the rats experienced
severe hypovolemia. Importantly, the hematocrit level was restored by Me2Spm therapy, implying
that the underlying cause of death could be a hypovolemic shock that is common in severe acute
pancreatitis. It was recently found that pancreatitis in MT-SSAT rats is associated with an early
systemic inflammatory response, and pretreatment of the animals with Me2Spm markedly reduces
serum TNF-a levels (Merentie et al., 2007). Spermine is, in fact, considered to be an inhibitor of the
immune response. For example, in human peripheral blood mononuclear cells, spermine dose-
dependently inhibits lipopolysaccharide-induced synthesis of TNF-a, IL-1 and IL-6 (Zhang et al.,
1997). TNF-a is a powerful mediator of inflammatory processes, especially in the liver (Malleo et
al., 2007) and it can also trigger coagulopathy through tissue factor expression (Esmon 2004).
Alternatively, tissue factor can be activated by pancreatic proteolytic enzymes, which are released
during tissue injury. It is also known that hypovolemic shock frequently activates intravascular
coagulation and ultimately leads to DIC (Garcia-Barreno et al., 1978). The possible contribution of
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severe coagulopathy to the high mortality rate in the MT-SSAT transgenic rat model is currently
under investigation. Overall, the results suggest that polyamine analog therapy might represent a
novel therapeutic approach to reduce severe pancreatitis-associated mortality.
The fundamental questions in polyamine research are: what are the individual roles of putrescine,
spermidine and spermine in different cellular processes and are these polyamines interchangeable.
To assess these questions, we synthesized and used stereochemically pure isomers of MeSpd and
Me2Spm, and observed that these stereoisomers have different biological properties and thus
represent convenient tools in polyamine research (IV). (S,S)-Me2Spm was metabolized by SMO to
some extent in vivo and in vitro, while (R,R)-Me2Spm did not show any detectable degradation. The
results revealed that SMO and deoxyhypusine synthase possess dormant stereospecificity. The
stereospecifity of the latter enzyme was demonstrated earlier by Lee and Folk, who tested the
inhibitory properties of several branched-chain derivatives of 1,7-diaminoheptane, including
different enantiomers (Lee and Folk 1998). Similarly, it was recently found that polyamine oxidase,
which normally uses achiral substrates, also exhibits stereospecificity that can even be controlled by
aldehyde “guide molecules" (Järvinen et al., 2006a; Järvinen et al., 2006b). This stereospecific
feature of these enzymes may well be further exploited to manipulate the cellular polyamine pools
and to dissect their physiological functions.
Although only the (S,S)-isomer was metabolized to MeSpd, both (S,S)- and (R,R)-isomers were
equally effective as racemic MeSpd in alleviating zinc-induced pancreatitis and restoring the
regeneration of liver after partial hepatectomy in MT-SSAT rats. Similarly, all stereoisomers of
MeSpd and Me2Spm were able to reverse polyamine depletion-induced acute growth arrest in cell
culture. Previously, it has not been possible to assess whether Me2Spm itself can support growth
since racemic Me2Spm is metabolized to MeSpd to some extent. Our results demonstrate that the
greatly elevated spermine pool can substitute for spermidine in reversing acute polyamine
depletion-induced cytostasis, both in vitro and in vivo, and help to preserve tissue integrity. The
importance of total polyamine pool maintenance on cell growth is demonstrated also by studies
using inhibitors of spermidine synthase and spermine synthase (Beppu et al., 1995). Although the
spermidine synthase inhibitor, trans-4-methylcyclohexylamine (4MCHA) effectively depletes
spermidine, and the spermine synthase inhibitor, N-(3-aminopropyl) cyclohexylamine (APCHA)
depletes spermine, neither of these compounds inhibits cell growth, apparently due to the
compensatory elevation of other polyamine pools. Furthermore, depletion of all three polyamines by
combination of DFMO and APCHA results in a more severe inhibition of cell growth than with
DFMO alone, whereas the combination of DFMO and 4MCHA (only putrescine and spermidine are
depleted) does not (He et al., 1995). These findings support the conclusion that spermidine and
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spermine are exhangeable in supporting short-term proliferation, i.e. when the hypusinated eIF5A is
not depleted. Despite years of research, the mechanism(s) of polyamine depletion-induced acute
growth arrest is still not understood. It is probably related to their electrostatic interactions with
cellular macromolecules, since either spermidine or spermine suffice, as long as the total polyamine
pool is maintained sufficiently high. The role of spermine in eukaryotes is interesting, since it is
clearly not of vital importance for proliferation. This is demonstrated for example by the existence
of gyro (Gy/Y)-mice, which have an X-linked mutation and completely lack spermine due to the
absence of spermine synthase gene (Lorenz et al., 1998; Meyer et al., 1998). The lack of spermine
in these animals is compensated by high spermidine content and increase in biosynthetic enzyme
activities. Although spermine deficiency is not embryonically lethal, the mice display a phenotype
characterized by small size, increased postnatal mortality, sterility, deafness, hyperactivity and
behavioral problems, that are all linked specifically to spermine deficiency (Wang et al., 2004). In
that sense spermine does play an important role in vertebrates. The embryonic fibroblasts derived
from Gy/Y-mice (Mackintosh and Pegg 2000) and cells with targeted disruption of the spermine
synthase gene have similar growth rates as the parental cells, although they are more sensitive to
polyamine analogs and inhibitors of polyamine biosynthesis (Korhonen et al., 2001).
After a prolonged time, spermidine depletion leads to depletion of hypusinated eIF5A and
subsequent cytostasis. In this way, spermidine and spermine are not exchangeable, since a
continuous supply of spermidine is needed for hypusination of eIF5A. However, since the half-life
of eIF5A is very long (approximately a week or more depending on the cell type), transient
fluctuations in spermidine pool do not alter mature eIF5A levels. Cells have also evolved an elegant
system to modulate spermidine levels via uptake, excretion, biosynthesis and interconversion by
SSAT/PAO or SMO. Although many polyamine analogs relieve the growth inhibition in short-term
experiments, at present only two analogs are capable of reversing hypusine-dependent cytostasis: an
unsaturated spermidine derivative (Byers et al., 1992), and racemic MeSpd (Byers et al., 1994). Our
results (IV) demonstrate that only the (S)-isomer of MeSpd serves as a precursor for hypusination of
eIF5A. Hypusinated eIF5A has been shown to take part in various processes. For example, it is
essential for the replication of the human immunodeficiency virus, by binding to the complex
formed by Rev and the Rev-response element in the stem-loop structure of the viral mRNA (Ruhl et
al., 1993). Both deoxyhypusine and hypusine-containing eIF5A are able to bind to the Rev-response
element, whereas unmodified protein is not, pointing to a crucial role for spermidine in viral
replication (Liu et al., 1997). Recently Xu and colleagues identified the eIF5A recognition sites
present in the Rev-response element, and found also new RNA targets of eIF5A binding (Xu et al.,
2004). These findings will facilitate the elucidation of the physiological roles of eIF5A.
Interestingly, eIF5A has been suggested to play some role also in NMD (Schrader et al., 2006).
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We found that the alternative splice variant of SSAT was not translated into functional protein
instead being subjected to degradation by NMD (II). Furthermore, it was found that the intracellular
polyamine level modulated the alternative splicing of SSAT. This novel regulatory pathway of
SSAT is known as regulated unproductive splicing and translation, or RUST. There has been much
debate on whether alternative splicing-coupled NMD represents an actual regulation mechanism or
is merely an evolutionary relic, caused by mutations, and persisting because there is no selection
pressure. It proved to be difficult to assess if RUST had physiological relevance as a regulator of
SSAT activity. One reason was that the basal level of SSAT is very low. In addition, it is difficult to
assess the extent to which RUST affects SSAT protein levels since many structural mimetics of
natural polyamines powerfully stabilize SSAT enzyme protein. Natural polyamines, which do not
stabilize the enzyme as effectively as some of their analogs, were indeed found to decrease the
SSAT-X/SSAT mRNA ratio, and subsequently to increase SSAT activity. Furthermore, SSAT-X
generation was favored by using drugs that deplete polyamines. These findings indicate that SSAT-
X does not merely exist as low level “background”, but the ratio of the two splice variants is
regulated. Silencing of SSAT-X mRNA using RNA interference was attempted, but due to the
strong secondary structure of exon X, none of the tested siRNAs was effective enough (our
unpublished observations). Recently, our experiments have indicated that transfection of SSAT-
deficient mouse fetal fibroblasts with mutated genomic SSAT, which is able to produce only SSAT
but not SSAT-X, results in increased SSAT activity when compared with cells transfected with
normal genomic SSAT (our unpublished observations). When transfected cells are treated with
DENSpm, the difference between normal and mutated SSAT disappears. Based on the obtained
findings, the unproductive splicing and translation seems to be an important mechanism by which
the natural polyamines can regulate the activity of the SSAT pathway.
The exact mechanism of polyamines' action on alternative splicing of SSAT is not known at present,
but several possibilities exist. Basically, polyamines can bind to and affect DNA, RNA or protein
function. Polyamines are known to promote transcription of some genes (like SSAT) by binding to
specific polyamine-responsive elements in DNA. Therefore, they could modulate splice factor
transcription through promoter region PRE. However, since DENSpm was able to decrease the
production of SSAT-X in the presence of CHX, de novo protein synthesis is apparently not needed
for polyamine-mediated regulation of splicing. Since polyamines are known to interact with RNA, it
is possible that polyamine binding in SSAT pre-mRNA induces a conformational change in RNA in
such a way that splicing is directed to produce functional SSAT. The polyamine binding may block
specific exonic or intronic splicing enhancer or silencer elements present in pre-mRNA. An
example of this kind of specific polyamine binding to RNA is the induction of +1 ribosomal
frameshifting in ODC antizyme RNA (Ivanov et al., 2000). Another possibility is that polyamines
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interact with proteins of the splicing machinery, leading to conformational change-induced
activation or inactivation. An example is polyamine analog-mediated conformational change and
stabilization of SSAT enzyme protein. It was recently found that DENSpm enhances SSAT
translation by displacing a repressor protein bound to the SSAT transcript (Butcher et al., 2007).
However, it was not clear whether this enhancement was due to an interaction of DENSpm with
RNA, repressor protein, or both.
It seems that RUST is involved in the regulation of several genes, many of which are splice factors
themselves. In most cases, alternative splicing is regulated by resulting protein product. We found
that this was not the case with SSAT, since both MG132 (increased SSAT protein, decreased
polyamines) and DFMO (decreased SSAT protein, decreased polyamines) resulted in SSAT-X
upregulation. Perhaps it is not surprising that polyamines are able to modulate the splicing of SSAT,
but we also obtained evidence that splicing of other gene transcripts was somewhat modified by
altered intracellular polyamine levels. This raises the question of whether these changes have any
regulatory function, or are merely caused by cellular stress. Alternative, nonsense codon-bearing
messages are frequently induced in response to various types of cellular stress and they are thought
to appear only because the protein synthesis capacity is reduced. However, one would expect that
keeping polyamine levels high by downregulation of SSAT would be beneficial for cells in
conditions of stress. It was difficult to find a treatment which can modulate polyamine pools without
causing general stress. The widely used inhibitors of polyamine biosynthesis such as DFMO as well
as synthetic polyamine analogs probably all cause some cellular stress. Despite this fact, SSAT-X
was induced only when polyamine levels were depleted, and decreased when polyamine levels were
elevated. Moreover, a clear correlation between the cellular polyamine content (spermidine +
spermine + their analogs) and the SSAT splice variant balance was found. Alternative splicing,
giving rise to multiple protein isoforms or coupled with NMD, is emerging as a novel regulatory
pathway. It is interesting that many of the genes related to polyamine metabolism, such as PAO,
SMO and PMF can undergo alternative splicing. By examining exon-intron organizations, it seems
that at least three mouse SMO variants, namely e, h and w, are potential NMD targets (our
unpublished observations). Interestingly, modulation of polyamine pools caused changes in the ratio
of productive and unproductive splice variants of Clk1. Clk1 is itself a modulator of alternative
splicing, through phosphorylation of serine/arginine-rich splicing proteins. A more thorough
analysis of splice variant expression of multiple genes was beyond the scope of this (II) study, but
keeping in mind the wide variety of suggested physiological functions of polyamines, it would not
be surprising if polyamines could regulate the splicing of a legion of genes involved in cellular
processes such as growth, differentiation and protein synthesis.
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7 SUMMARY
This study was undertaken to investigate the functions and homeostasis of polyamines in various
important cellular processes using different in vitro and in vivo models. It also aimed to investigate
the utility of stable a-methylated polyamine analogs and their stereoisomers as therapeutic agents
for treating acute pancreatitis and as tools to study the function of the individual polyamines. The
following results were obtained
I Activation of polyamine catabolism and subsequent polyamine depletion is a general
event in cerulein and L-arginine-induced experimental models of acute pancreatitis,
and in the latter model the symptoms of the disease can be alleviated by prior
administration of stable a-methylated polyamine analogs. Polyamine depletion may
also contribute to the development of human pancreatitis. Furthermore, pancreatitis-
associated mortality in polyamine catabolism-induced acute pancreatitis in MT-
SSAT-transgenic rats is dramatically reduced by treatment with these analogs.
II Polyamine catabolism-induced acute pancreatitis is associated with early activation of
both trypsinogen and cathepsin B. The zymogen activation can be reduced by prior
administration of a-methylated polyamine analogs.
III Intracellular polyamine levels regulate the alternative splicing of SSAT pre-mRNA.
When polyamines are in excess, productive SSAT mRNA generating functional
SSAT protein is produced. In contrast, polyamine depletion favors the generation of
unproductive mRNA which is rapidly degraded by a nonsense-mediated mRNA
decay mechanism. Thus, polyamine-regulated unproductive splicing and translation is
a novel posttranscriptional regulation mechanism of SSAT.
IV Several enzymes of polyamine metabolism which normally use achiral molecules as a
substrate, display dormant stereospecificity towards chiral stereoisomers of the a-
methylated polyamine analogs. Only (S)-isomer of MeSpd serves as a substrate for
deoxyhypusine synthase and (S,S)-isomer of Me2Spm for spermine oxidase.
V All stereoisomers of MeSpd and Me2Spm rescue the cells from acute DFMO-induced
cytostasis in DU145-cells, prevent the development of zinc-induced pancreatitis and
restore liver regeneration in MT-SSAT transgenic rats.  However, of the
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stereoisomers, only (S)-MeSpd can serve as a precursor for hypusinated eIF5A and
thus support the growth of DFMO-treated DU145-cells for over a week.
These findings demonstrate that disturbed regulation of SSAT has remarkable consequences on
cellular proliferation and tissue integrity. These changes are attributable to polyamine depletion, and
can be counteracted with stable a-methylated polyamine analogs. In particular the stereoisomers of
methylpolyamines are convenient tools for studying hypusine-independent and -dependent effects
of polyamines on cellular processes and for dissecting the role(s) of the individual polyamines.
Our findings open up novel possibilities for clinical applications.
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